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1.1  Introduction and Motivation 
 Dysplastic lesions of the cervix, or Squamous Intraepithelial Lesions (SIL), are precursor 
lesions in the development of cervical cancer. If these precursor lesions can be detected early in 
the progression of disease, early treatment can prevent the progression to invasive cervical 
carcinoma. Although the widespread application of the Papanicolaou (Pap) smear as a screening 
tool has greatly decreased the incidence of cervical cancer [1], sampling and reading errors lead 
to high false positive and negative rates. The most recent meta-analysis of the accuracy showed 
that in low prevalence populations, the mean sensitivity and specificity of the Pap smear was 
48% and 95%, respectively [2].  
 Raman spectroscopy has the potential to be a more accurate screening and diagnostic 
device. The sensitivity and specificity of Raman spectroscopy in differentiating dysplasia from 
all other tissue categories (including normal, squamous metaplasia and inflammation) in vitro 
was 82% and 92% [3], respectively. A pilot in vivo study found that using a simple algorithm, 
based on two Raman intensity ratios, Raman spectroscopy can separate high grade lesions from 
all others [6].  
 Since spectral measurements and analysis can be done in real-time (i.e. without 
pathologist intervention), Raman spectroscopy also has the potential to be a more cost effective 
means of screening and diagnosis. A study in Obstetrics and Gynecology in 1998 [4] concluded 
that managing cervical SILs with a “see and treat” strategy in which real-time diagnosis with 
spectroscopy was immediately followed by treatment with LEEP (Loop Electrocautery Excision 
Procedure) was more cost effective than the traditional colposcopy directed biopsy, followed by 
pathologic examination of the biopsy with treatment by LEEP at a later date.  
 This see and treat strategy also has implications for diagnosing and treating high-risk 
populations. Patients who do not have access to regular medical care, such as low-income 
populations or patients in developing countries, often do not receive proper screening and/or 
follow-up treatment. Lifestyle changes in these populations have led to an increased transmission 
of Human Papillomavirus (HPV) and a consequent rise in squamous cell carcinoma, for which 
the contraction of HPV is a known risk factor [5].  Additionally, in many Latin American 
countries, the incidence of cervical cancer has remained constant despite large screening efforts 
due to a lack of infrastructure for quality cytologic diagnosis and the absence of follow-up 
programs for treatment [5]. A see and treat method would reduce these problems by allowing 
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screening and certain treatments to be conducted simultaneously, therefore moderating the 
necessity of follow-up patient visits. The see and treat system would also save time and expenses 
for those patients needing to travel long distances for medical care. 
 In this thesis, the potential of using Raman spectroscopy for the detection of cervical 
dysplasia is examined with the long term goal of using Raman spectroscopy as part of a see and 
treat strategy for the screening of cervical cancer. 
 
1.2  Specific Aims 
 To evaluate the potential of Raman spectroscopy to distinguish different pathologies in 
the cervix, the following specific aims were developed: 
1.) Characterize the Raman spectral differences of different cervical tissue types in vivo for 
differential diagnosis of cervical lesions. 
Raman spectra of the cervix were measured in vivo prior to the removal of the tissue during 
excisional procedures of the cervix. These spectra were examined to determine the spectral 
features unique to each class of cervix pathology. 
2.) Characterize the sources of variation with a given pathology category.   
A second clinical study was designed to measure Raman spectra from areas of normal cervix in 
patients without evidence of cervical dysplasia. Multiple spectra of normal appearing areas were 
measured in each patient prior to hysterectomy procedures allowing for determination of the 
optimal measurement time, effects from acetic acid, and components of variance.  
3.) Develop algorithms based on multivariate statistics to automatically distinguish the spectra of 
normal cervix, inflammation, metaplasia, low grade SIL and high grade SIL.  
The Raman spectra were grouped into categories according to the histologic diagnosis. A model 
using two logistic regression algorithms was developed to separate high grade dysplasia from 
benign areas of the cervix.  
4.) Determine the biochemical and cellular basis for the differences seen in spectra of different 
tissue types. 
To better understand the biochemical and cellular changes seen in specific aim1, organotypic raft 
tissue cultures that mimic the biochemical and cellular composition of the normal and dysplastic 
cervix were constructed, and Raman spectra of the intact tissue cultures and separate tissue 
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layers were measured individually. An understanding of the cellular contributions to the Raman 
spectra enhanced the characterization of the spectral differences between tissue categories.  
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2.1  Anatomy and Histology of the Cervix 
 The Cervix is most inferior portion of the uterus and measures 2.5-3 cm in length in the 
nulliparous adult woman [1]. A small orifice in the center of the cervix, termed the external os, 
serves as the connection and passageway between the uterine corpus and vagina.   
 The three zones of the cervix are defined by the type of epithelium: the ectocervix on the 
periphery of the cervix with stratified squamous epithelium, the endocervix lining the external os 
with columnar epithelium, and the transformation zone which marks the border between the 
columnar and stratified squamous epithelial zones.  The transformation zone is significant 
because most cervical cancers arise from this area. Underlying the epithelium in all three zones is 
the stromal layer primarily consisting of collagen devoid of any endometrial glands, 
characteristic of the stroma of the uterine corpus. The stromal layer also contains fibroblasts, 
inflammatory cells, and capillary beds.  
 The stratified squamous epithelium is 15 to 20 cells thick with a thickness of 200-400 
microns.  The maturation process begins in the layer of basal cells. Basal cells are elliptical cells 
with large oval nuclei and high mitotic activity. As they mature, these cells migrate to the 
surface, accumulate glycogen in the cytoplasm, and acquire a flattened shape. Eventually, the  
basal cells are shed in the desquamation process and the entire epithelium is replenished, which 
typically occurs over the course of 4-5 days [2]. 
 
2.2  Cervical Dysplasia  
 Dysplasia is defined as “disordered growth” and is generally thought of as a step in the 
development of invasive cancer [3]. Although not all dysplastic lesions will progress to invasive 
cancer, early detection and treatment of dysplastic lesions in the cervix is an important and 
effective method for the prevention of invasive cancer [4]. 
 The majority of dysplastic lesions arise in the transformation zone, where the 
acidic environment of the vagina induces areas of columnar epithelium to transform into the 
more protective stratified squamous epithelium.  This  process is termed metaplasia. This 
metaplastic transformation provides an environment ripe for the initiation of dysplastic changes. 
Overwhelming evidence implicates HPV, a sexually transmitted virus infecting the squamous 
cells of the cervix, as the most important factor in the initiation of the pathogenesis of cervical 
cancer [5]. Figure 2.1 shows the theoretical process by which cervical cancers develop [3]. 
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Figure  2.1: Diagram illustrating the stages of development of cervical cancer [3] 
 
 
 Different strains of HPV are known to confer different risks of developing invasive 
carcinoma.  The strains conferring the greatest risk of inducing neoplastic changes (“high risk 
HPVs”) are those that integrate their viral DNA into the host cell DNA.  This integration disrupts 
the open reading frame of the viral gene E2, which is known to regulate expression of viral genes 
E6 and E7.  Overexpression of E6 and E7 confers immortality to the host cell via inhibition of 
host cell tumor suppressor gene products p53 and Rb, respectively. Conversely, “low risk HPV” 
strains typically do not integrate into the host cell genome, and are consequently more likely to 
produce warts or hyperkeratosis than dysplastic changes[3].  
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Figure  2.2: Progression from normal epithelium to carcinoma in situ (CIS).  
Below the illustration, the corresponding classification is denoted.  The top classification row (CIN) refers to the 
histological diagnosis; the bottom row refers to the cytological diagnosis as defined by the Bethesda system [2]. 
 
 
 The stages of tissue progression from normal to dysplasia are shown in figure 2 with the 
corresponding diagnostic classifications. Cervical Intraepithelial Neoplasia (CIN) is a general 
term for dysplastic changes limited to the epithelium of the cervix. Dysplasia is characterized by 
a decrease in cytoplasm and glycogen levels, and a rise in mitotic activity.  Similarly 
characteristic of dysplastic lesions are the regional increases in nuclear size and DNA quantity 
associated with the intensified mitotic activity. Morphologically, dysplastic cells resemble 
undifferentiated basal cells, but unlike normal basal cells, dysplastic cells exhibit large 
hyperchromatic nuclei, chromatin clumping, irregular nuclear borders and scant cytoplasm [3]. 
As the degree of atypia and number of dysplastic cells increase, the grade of the dysplasia is 
increased, with CIN III representing the highest grade of dysplasia including both severe 
dysplasia and carcinoma in situ. The Bethesda system was developed in 1988 as a method of 
grouping the pathological categories based on the course of treatment [6]. In this system, changes 
associated with HPV infection and CIN I are grouped together as low grade SIL whereas CIN 
II/III are grouped together as high grade SIL. 
 The development of cancer of the cervix is typically a slow process, taking 
several years for the transformation from normal epithelium to dysplasia to invasive carcinoma. 
This slow progression makes it possible for screening programs to detect neoplastic processes 
before invasive carcinoma develops.  Early detection and treatment remains critical for 
successful eradication of the disease. Screening programs are designed to detect dysplasia in an 
effort to curb the incidence rate of carcinoma.  
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2.3  Current Methods of Screening/Diagnosis 
 
2.3.1  Pap Smear 
 The Pap Smear (named after George Papanicolaou who first developed the technique) is 
a method of screening for cervical neoplasia by sampling exofoliated cells from the surface of 
the endocervical canal and ectocervix. A small spatula is used to first scrape cells from the 
ectocervix.  Following this, the endocervical canal is sampled by inserting a cytological brush 
through the external os.  The collected material is traditionally placed on a glass slide and fixed 
with a spray fixative. Since the widespread implementation of the Pap smear as a screening tool, 
the incidence of and mortality from cervical cancer has decreased dramatically in developed 
nations [7]. Yet, research into improving or replacing the Pap smear has increased due to 
concerns about its inefficiency and low sensitivity (30%-87%) [8, 9]. The low sensitivity is a 
product of sampling error, laboratory error, and interobserver error [10]. Sampling Error is 
estimated to contribute 66% of the overall false negative rate and typically occurs when 
abnormal cells are not acquired, collected cells are inadequately transferred to the slide, or cell 
clumping/artifacts on the slide obscure proper assessment of collected cells. The remaining 33% 
of the false negative rate can be attributed to a combination of laboratory error (errors in 
processing of the slides) and interobserver error (variation due to the subjective nature of 
screening Pap smear slides) [10, 11]. 
 
2.3.2  Colposcopy 
 Typically, if a Pap smear shows abnormal cells, a woman will be referred for a 
colposcopic examination in which the cervix is visualized by a magnifying colposcope (4-40X).  
The surface of the cervix is swabbed with a solution of 4% acetic acid which causes areas of 
abnormal epithelium to turn white.  The acetowhitening of the epithelium slowly decays over 
several minutes but can be maintained by re-application of acetic acid.  The degree of 
acetowhitening can be quantified (0, 1/2+, 1+, 2+), but such quantification is highly subjective. 
An iodine solution, which stains normal squamous epithelium but not normal columnar 
epithelium or abnormal epithelium, is often used to enhance the contrast of the transitional zone. 
Colposcopy, in expert hands, has been shown to be a very sensitive technique of identifying 
areas of abnormal epithelium with a sensitivity of 96%. Yet colposcopy often mistakes benign 
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changes of epithelium, such as squamous metaplasia and inflammation, for dysplasia, resulting 
in a low specificity (average specificity: 48%) [12]. Thus, to obtain a definitive diagnosis, the 
colposcopic diagnosis often must be confirmed with one or more biopsies.  The need to confirm 
diagnosis with biopsy and histology increases patient pain and inconvenience, cost of disease 
management, and patients lost to follow-up as adherence with repeat colposcopy is 7-50% 
depending on patient population [13]. 
 
2.3.3  HPV testing 
 Studies have shown that women infected with HPV are more likely to develop low grade 
SIL than those without evidence of infection [5]. Infections with high risk types of HPV (16, 18) 
have higher rates of progression to high grade SIL than infection with low risk types (6, 11) [8]. 
Thus, HPV testing has been proposed as screening method to determine which women are at 
high risk for developing cervical neoplasia. The main benefit to using HPV testing as a screening 
tool lies in the extremely low false negative rate and high sensitivity (83%-100%) for detecting 
HSIL and carcinoma.  Because not all women infected with HPV will have lesions that progress 
to SIL, the specificity of HPV testing hovers around 78%, and thus has not gained widespread 
acceptance as a primary screening tool [14-16]. 
 HPV testing has been shown to be a more effective tool in triaging women when the 
results from a Pap Smear show Atypical Squamous Cells of Undetermined Significance 
(ASCUS) [17].  Since only a minority of these lesions will progress to higher grade lesions, HPV 
testing can aid in determining which women should be evaluated with colposcopy due to the 
increased likelihood that legions in women infected with HPV will progress to high grade SIL 
[8]. Since the vast majority (85%) of LSIL will test positive during HPV screening, HPV testing 
is no longer recommended as a method for triaging patients with a LSIL Pap smear for 
colposcopy [17]. 
 
2.3.4  A flawed gold standard 
 It should be noted that the calculations of accuracy for all of these screening and 
diagnostic tests are based on comparisons with histopathologic diagnosis on biopsy or other 
cervical tissue specimen, which is considered the gold standard for diagnosis of cervical 
dysplasia and invasive carcinoma. Yet, because histopathologic diagnoses are dependent on the 
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interpretation of one or more pathologists, the gold standard is not perfect and subject to 
variability. Analysis from the Atypical Squamous Cells of Undetermined Significance-Low 
Grade Squamous Intraepthelial Lesion (ALTS) Triage Study has shown that the histopathologic 
interpretations of punch biopsy (k=0.46) and LEEP (k= 0.49) (with k=1 representing exact 
agreement and k=0 representing poor agreement) can be extremely variable, even between 
pathologists at academic medical institutions [18]. Most of the variability in interpretation comes 
in distinguishing intermediate grades of pathology such as low grade dysplasia. Only 43% of low 
grade dysplasia interpretations were reproduced while 90% of normal and 76% of high grade 
dysplasia interpretations were corroborated [18]. Thus it should be noted that one of the inherent 
difficulties in assessing the accuracy of any new technology is comparison with a flawed gold 
standard. 
 
2.4  New Technologies in Cervical Cancer Screening 
 Several new technologies have emerged in recent years aimed at improving the accuracy 
and accessibility of cervical cancer screening. Four of these have been implemented as possible 
alternatives to the current standard of treatment and diagnosis: liquid-based thin-layer cytology, 
computer-assisted cytologic screening and rescreening, visual inspection, and cervicography. 
Thin Prep® is a liquid-based cytologic preparation designed to reduce the number of errors due 
to sampling loss and preparation issues such as drying artifacts on traditional slides of cervical 
specimens. PAPNET® and AutoPAP® are computerized screening applications intended to 
reduce the number of false negative results attributable to reading errors.  With visual inspection, 
a technique used in regions lacking the economic resources to fund more expensive alternatives, 
the cervix is examined with the unaided eye after the application of an acetic acid wash. Finally, 
cervicography is the use of high quality photographs of the cervix taken by trained technicians 
which then can be read in a manner similar to colposcopy, by an expert either locally or 
elsewhere. Of all of these, only Thin Prep® has been widely implemented [19].  
 With the exception of visual inspection, all of these new technologies add to the cost of 
cervical cancer screening, and none of them address the primary cause of diagnosis error in Pap 
smears, namely the failure to sample the abnormal cells from the cervix. In addition, all of the 
aforementioned technologies still require that a specimen (or picture) be sent off for evaluation, 
resulting in a lapse between the time a patient is evaluated and to the time a diagnosis can be 
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made.  A technology that could eliminate this time lapse would enhance the quality of care and 
reduce the level of patient anxiety, as treatment decisions could be made at the time of initial 
evaluation. A real-time diagnosis would enhance the cost and time efficiency of the screening 
process by eliminating the additional time and cost of pathological diagnosis and reducing the 
number of visits to health care providers. Thus, methods of optical diagnosis, specifically optical 
spectroscopy, are considered here as a means for providing non-invasive, real-time diagnosis. 
 
2.5  Use of Spectroscopy in Diagnosis of Cervical Lesions 
 Optical techniques, particularly optical spectroscopy, increasingly are being applied to 
detect pathology due to their ability to provide real-time, non-intrusive, and automated 
information. 
 
2.5.1  Fluorescence Spectroscopy 
 Laser induced fluorescence spectroscopy is the most extensively investigated type of 
spectroscopy for the diagnosis of cervical dysplasia. In the most complete study to date, 
Richards-Kortum and co-workers measured 359 fluorescence spectra of cervical tissue in vivo 
from 95 patients prior to cervical biopsy using three (337, 380, and 460 nm) excitation 
wavelengths [20]. Classification was performed using a multivariate algorithm that employed 
principal components analysis for data reduction and an algorithm based on Bayes’ theorem for 
discrimination. This multivariate technique was able to separate high grade dysplasia from all 
other cervical pathologies with a sensitivity of 79% and specificity of 78%. A separate (but 
similarly derived) algorithm separated all dysplastic lesions from all benign pathologies with a 
sensitivity of 82% and a specificity of 68%. Prospective classification of the data using a radial 
basis function (neural) network yielded analogous results [21].  
 Further analysis of the fluorescence data shows that the low accuracy is due primarily to 
the similarity of the spectra of squamous metaplasia and dysplasia leading to difficulties in 
distinguishing squamous metaplasia from dysplasia spectra, a problem also seen with colposcopy 
[20]. In attempt to improve the accuracy of fluorescence in separating metaplasia from dysplasia, 
there have been several studies investigating the use of fluorescence spectroscopy in combination 
with diffuse reflectance and/or light scattering spectroscopy. Diffuse reflectance spectroscopy 
measures the elastic scattering of light over a range of wavelengths, and using the light diffusion 
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theory, information regarding the optical properties of tissue can be extracted from the spectrum 
to provide information on the morphology and biochemistry of the stroma [22]. Light scattering 
spectroscopy measures the reflected light from only the superficial epithelial layer using 
polarized spectroscopy allowing for estimation of amount and sizes of epithelial cell nuclei [23].   
Nordstrom et.al. [24] developed a system to scan the cervix, collecting a fluorescence and 
diffuse reflectance spectrum for 120 distinct areas. Although the system performed reasonably 
well when distinguishing both normal ectocervix from CIN I, achieving an 86% sensitivity and 
87% specificity, and normal ectocervix from CINII/III, achieving a 91% sensitivity and 93% 
specificity, it was only able to distinguish squamous metaplasia  from high grade dysplasia with 
a 77% sensitivity and 76% specificity.  Georgakoudi et. al. added light scattering spectroscopy to 
fluorescence and diffuse reflectance spectroscopy (termed trimodal spectroscopy) to measure 
spectra in a study of 44 patients [22]. Using logistic regression and leave-one-out validation, 
trimodal spectroscopy was able to classify SIL versus non-SIL (benign) with a sensitivity of 92% 
and specificity of 71%. Development of trimodal spectroscopy for use as a fully functional, real-
time imaging system is ongoing [25]. 
 
2.5.2  Near Infrared Absorption Spectroscopy 
 Although near-infrared spectroscopy (NIR) has been investigated for its potential uses in 
in vitro diagnosis, NIR has had limited in vivo applications due to the inability to use the same 
fiber optic probe for incident and collection light. Tromberg and co-workers [26] employed a 
technique termed frequency domain photon migration to overcome this limitation.  In their study 
of ten patients being treated for high grade dysplasia with photodynamic therapy, absorption and 
scattering coefficients at 956 nm were shown to be significantly different between high grade 
dysplasia and normal cervix, yet no data was collected on low grade dysplasia, squamous 
metaplasia, or inflammation, three pathologies important for diagnosis of the cervix. 
 
2.5.3  Confocal Imaging 
 Instead of analyzing reflected light spectrally, the reflected light can be collected to form 
an image which can be visually inspected and analyzed to give diagnostic information. In 
confocal imaging, light is collected from specific depths within the tissue, producing depth 
resolved images similar to histology sections of tissue.  In an in vitro study, Collier et. al. 
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collected confocal images from biopsy specimens of colposcopically normal and abnormal areas 
of cervix from 19 patients. The nuclear-cytoplasmic ratio, calculated using image processing 
software, was able to distinguish CIN II/III from all others with a sensitivity and specificity of 
100% and 91% respectively [27]. A second study by Collier et. al. found that application of 
acetic acid prior to collection of confocal images enhanced the nuclear contrast in the image in 
both normal and abnormal biopsy specimens; the effect served to increase the contrast between 
normal and dysplastic images [28]. Although the results of these studies are promising, the 
images were collected using a system designed in house to be a benchtop system.  In order to 
evaluate the potential of this technology in vivo, a portable system, capable of taking 
measurements in a clinical setting, must be designed and implemented. 
 
2.5.4  Cost Effectiveness of Spectroscopy 
 In an analysis of the cost effectiveness of different strategies for diagnosis and treatment, 
Cantor et. al. [29] found that the most cost effective strategy for management of abnormal Pap 
smears was a “see and treat” strategy incorporating fluorescence spectroscopy. Colposcopically 
directed biopsy, the current standard of care, was the most expensive but also the most accurate. 
Thus, if a method of spectroscopy could be developed, with the accuracy of colposcopically-
directed biopsy, its cost effectiveness could make spectroscopy a viable alternative to the current 
standard of care. 
 
2.6  Raman Spectroscopy for Diagnosis of Cervical Lesions 
 
2.6.1  What is Raman Spectroscopy? 
 Raman spectroscopy is a molecular specific spectroscopy in which individual bonds are 
probed. When a photon is incident on a molecule, the light can be absorbed or scattered. 
Fluorescence and near infrared spectroscopy rely on the absorption of light (and subsequent 
emission of energy in the case of fluorescence). The Raman effect results from inelastic 
scattering. During scattering, the photon can reflect off the incident molecule with or without a 
transfer of energy. Elastic scattering denotes scattering which occurs without a transfer of energy 
such that the reflected photon leaves the interaction with the same amount of energy (and thus at 
the same wavelength) as the incident photon. Inelastic scattering occurs when energy is 
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transferred between the incident photon and the molecule causing a change in the vibrational 
energy of the bonds within the molecule. The energy transfer causes a shift in the wavelength of 
the scattered photons. Raman spectroscopy is a measure of this inelastic scattering in which the 
intensity of the scattering is plotted against the frequency corresponding to the energy lost or 
gained by the photon as it interacts with the substance [30].  Thus, this technique provides 
specific molecular information which results in the detection of subtle changes in molecular 
conformation and structure.  
 Raman spectroscopy traditionally has been used to study the structure and function of 
various molecules by analytical chemists and biochemists. More recently, researchers have 
begun to investigate the potential of Raman spectroscopy as a method of performing non-
invasive diagnosis of diseases such as cancer and atherosclerosis [31]. Thus far, in vitro studies 
of the gastrointestinal tract [32], larynx [33], breast [34], skin [35], cervix [36], lung [37], lymph 
nodes [38] prostate [39] brain [40] and in vivo studies of cervix [54], esophagus [41], skin [42], 
colon [43] and rat carcinogenesis models [44] have shown that Raman spectroscopy is a 
promising diagnostic tool for the discrimination of dysplastic and cancerous lesions. 
 
2.6.2  Discrimination Algorithms 
 In order to use spectral information to provide real time diagnosis, a mathematical 
algorithm or series of algorithms must be developed to extract clinically relevant information 
from the spectra and calculate a score or set of scores to classify the given spectrum into a 
category based on a predetermined set of criteria. The most robust method for developing and 
validating discrimination algorithms is to divide a data set into independent training and test sets. 
An algorithm or series of algorithms is fit to the data in the training set using the empirical or 
statistical method of choice, and the criteria for classification into specific categories is 
determined. Classification of the spectra in the test set determines the unbiased accuracy of the 
algorithm. In cases of small data sets (as is often the case in pilot studies), division of the data 
into training and test sets is not feasible.    
 The leave-one-out cross-validation method is a popular alternative to independent 
training and test sets. In the leave-one-out method, one spectrum is removed from the data set 
and the algorithm is derived using the remaining spectra. The algorithm is then tested using the 
removed spectrum.  This process is repeated for every spectrum in the data set, such that an 
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estimate of the potential accuracy of future algorithms developed using the method in question 
can be calculated.  In reality, the leave-one-out validation cannot be considered an unbiased 
estimate of accuracy. Often, it is difficult to leave out the spectrum throughout the entire 
algorithm development process, and thus the estimation of algorithms accuracy is inherently 
biased. Also, this technique is not effective for situations in which some spectra are related to 
one another, as is the case for multiple spectra attained from a single patient.   
 There have been a number of different empirical and multivariate statistical methods used 
to develop algorithms to discriminate between Raman spectra taken from cancerous and 
dysplastic tissue. One empirical method which has shown the most promise for separating 
spectra in different pathological groups is the calculation of peak ratios. Previous studies have 
used multiple peak ratios to effectively separate spectra of cervical dysplasia and normal cervix  
[36, 54]. Yet, empirical analysis techniques are limited in scope and subjective in nature.  
Spectral differences between the various categories of pathology may be subtle and not 
immediately recognizable, even to the trained eye.  Thus, the need exists to develop tools which 
can automate the classification process such that the classification is both objective and 
systematic. Several different multivariate techniques are effective for classification in spectral 
diagnosis, including: neural networks, [45, 46], hierarchical cluster analysis [47], and linear 
discrimination analysis (LDA) based on Bayes’ theorem [36].  
 Linear discrimination algorithms, such as Fisher’s Discriminate Algorithm (FDA) or 
Quadratic Discrimination Score (QDS) are often used to group or classify measurements into 
two or more categories [48]. Yet, such algorithms are computationally complex and do not 
perform well with large data matrices such as those seen in spectroscopy. Also, the number of 
inputs to a discrimination model must be lower than the number of spectra in the training set to 
avoid overfitting the model which would decrease the likelihood that the model would perform 
well on future data sets. Thus, one or more data reduction techniques must be employed before 
discrimination algorithms can be used for classification.   
 The most basic data reduction technique is empirical data reduction.  An examination of 
the data can yield a subjective assessment to determine which aspects of the spectrum are likely 
to be most useful for discrimination. If the biological basis of spectral differences seen between 
pathology categories is known, those spectral features with biological relevance can be 
empirically chosen as inputs for the model rather than choosing spectral features which are only 
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statistically different in the current data set. This strategy would increase the likelihood that the 
model inputs will perform equally well with future data sets. An objective method of identifying 
the variance within a data set is Principal Components Analysis (PCA).  PCA is a method that 
uses eigenvector decomposition of the covariance matrix to map the data onto a new set of 
orthogonal axes such that the variance within the data is maximized and concentrated into a few 
components. Each principal component describes a decreasing percentage of the total variance 
(as described by the eigenvalues) [48]. This allows the majority of the variance within a data set 
to be represented by a minimum number of variables.  Thus, data reduction with PCA allows for 
a minimum number of variables necessary for evaluation in discrimination algorithms without 
compromising the data variance.  
 The use of PCA for data reduction, followed by linear discrimination algorithms (LDA) 
for classification, has become a well established method for spectroscopic data analysis with a 
number of research groups employing the method specifically for discrimination of Raman 
spectra [41, 43, 44, 49]. There are some potential flaws to this system, including the restriction of 
discrimination to a linear surface and the potential to overfit the model to the data. One such 
alternative to the use of PCA, which has been used for classification in fluorescence, trimodal, 
near infrared absorption, and Raman spectroscopy, is logistic regression [22, 28, 50]. Logistic 
regression is a variation of linear regression in which there are only two outcomes.  The results 
of the linear regression are fit to a sigmoidal curve yielding a function that estimates the 
probability of an event happening based on the data input [51].  When used for spectral 
classification, the logistic regression algorithm will yield a score or probability that a given 
spectrum was measured from a high grade lesion (or category of choice).   
 
2.6.3  In vivo Raman spectroscopy for the detection of dysplasia and cancer 
 Although there has been extensive work on the characterization of Raman spectra for 
various tissue types in vitro, very few studies have investigated the diagnostic potential of 
Raman spectroscopy in vivo.  Bakker Schut et. al. used a rat carcinogenesis model to map the 
changes in Raman spectra which occur during neoplastic transformation in the oral cavity 
[44].Upon visual inspection of the data, increases were seen in the peak ~1006 cm-1 and region 
from 1300-1330 cm-1 when comparing spectra from normal tissue to dysplastic tissue.  A model 
using PCA for data reduction and LDA for discrimination with leave-one-out validation, was 
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able to detect low grade dysplasia with a sensitivity of 78% and specificity of 93% and high 
grade dysplasia and cancer with 100% sensitivity and specificity.  This study was the first to 
show the ability of Raman spectroscopy to detect dysplasia in vivo in a controlled model system. 
The results indicated that in a controlled model system devoid of significant intersubject 
variation, Raman spectroscopy is capable of detecting dysplastic changes with a high level of 
accuracy when compared to current methods. 
 Shim et. al. measured Raman spectra in vivo from 20 patients during upper or lower GI 
endoscopy [41]. Spectra were collected using a 5 second measurement time with signal to noise 
ratios ranging from 3 in the esophagus to 17 in the colon. Subtle changes in the spectra were 
noted between 1100-1800 cm-1 when comparing normal and pathologic states, but no attempt at 
spectral classification was made due to the small number of patients. Yet, this study represents a 
significant milestone as it is the first to record in vivo clinical Raman spectra measured with a 
clinically relevant signal collection time (5 seconds) and sufficient signal to noise ratio. In a 
subsequent study, Molckovsky et. al. measured Raman spectra from 19 adenotamous and 
hyperplastic polyps in vivo from 3 patients. Data reduction using PCA and classification using 
LDA with leave-one-out cross validation was used to develop a diagnostic algorithm which 
classified the data with 100% sensitivity and 89% specificity [43].  The authors also note in this 
study that an algorithm developed from an ex vivo study of colon polyps was not able to classify 
the in vivo data accurately, indicating that although in vitro and ex vivo studies may be able to 
predict whether Raman spectroscopy will succeed in vivo, diagnostic algorithms developed using 
data from ex vivo and in vitro data may not be translated for in vivo data. 
 Notably, several studies from Puppels and colleagues have demonstrated the 
measurement of Raman spectra from skin in vivo using a confocal Raman microspectrometer 
[35, 42, 52].  However, since none of these studies have looked cancerous or dysplastic changes 
of the skin they will not be detailed here. 
 
2.6.4  Previous Studies using Raman Spectroscopy for Diagnosis in the Cervix 
 In the first study investigating the potential of using Raman spectroscopy for diagnosis in 
the cervix, Mahadevan-Jansen et. al.[36] measured Raman spectra in vitro of 36 biopsies from18 
patients. Empirical peak intensities were found that differentiated dysplasia from benign 
pathologies with an average sensitivity and specificity of 88 % and 92% respectively. An 
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unbiased multivariate analysis using principal components analysis and linear discriminate 
algorithms separated dysplasia from all benign pathologies with a sensitivity and specificity of 
82% and 92% respectively. 
 This in vitro study was followed by a 13 patient study investigating the feasibility of 
using Raman spectroscopy for in vivo diagnosis [54]. A specialized fiber optic probe was 
designed to maximize throughput of Raman signal collection and minimize collection of diffuse 
reflectance and Raman peaks from the probe itself [53]. Measurements were collected prior to 
cervical biopsy, and a total of 24 measurements were suitable for analysis. A simple ratio of peak 
intensities was able to separate high grade dysplasia from all other pathology types 
misclassifying only one sample. 
  These two proof of principle studies show that Raman spectroscopy can be measured in 
vivo and has the potential to be a more accurate method of spectroscopic diagnosis than 
fluorescence spectroscopy, while retaining the cost-effectiveness and real-time diagnosis 
capability shown with fluorescence spectroscopy [29]. Yet, these studies only included small 
numbers of patients and used empirical algorithms based on subjective analysis of the data. Thus, 
although this study shows that Raman spectroscopy has the potential to be a useful tool for the 
detection of cervical dysplasia, further studies are needed to fully evaluate this potential. 
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3.1  Abstract 
 Raman Spectroscopy has been shown to have the potential for providing differential 
diagnosis in the cervix with high sensitivity and specificity in previous in vitro and in vivo 
studies. A clinical study was designed at Vanderbilt University Medical Center to further 
evaluate the potential of near infrared Raman spectroscopy to detect cervical dysplasia in a 
clinical setting. 
 Using a portable system, Raman spectra were collected from the cervix of 79 patients 
prior to excisional procedures using clinically feasible integration times (5 seconds). Multiple 
Raman spectral measurements were taken of colposcopically normal and abnormal areas prior to 
the excision of tissue. The Raman spectra were then extracted from the measured signals using 
signal processing, The resulting spectra were correlated with the corresponding histopathologic 
diagnosis to determine empirical differences between different diagnostic categories. Using 
histology as the gold standard, logistic regression discrimination algorithms were developed to 
distinguish between normal ectocervix, squamous metaplasia, and high grade dysplasia using 
independent training and validation sets of data. An unbiased estimate of the accuracy of the 
model indicates that Raman spectroscopy was able to distinguish between high grade dysplasia 
and benign areas of the cervix (normal ectocervix and squamous metaplasia) with sensitivity of 
89% and specificity 81% while colposcopy in expert hands was able to discriminate with a 
sensitivity of 87% and specificity of 72%. 
 
3.2  Introduction 
 If cervical dysplasia, a precursor lesion in the development of cervical cancer, can be 
detected early in the progression of disease, treatment can prevent the progression to invasive 
cervical carcinoma [1]. Although the widespread application of the Papanicolaou (Pap) smear as 
a screening tool has greatly decreased the incidence of cervical cancer, sampling and reading 
errors in the Pap smear lead to a high number of false positive results. The most recent meta-
analysis of the accuracy showed that in low prevalence populations, the mean sensitivity and 
specificity of the Pap smear was 48% and 95%, respectively [2]. The standard diagnostic method 
for women suspected of having dysplasia is colposcopy directed biopsy, a procedure in which 
the physician applies a 3-5% acetic acid solution to the cervix and examines it under a 
magnifying (14X) colposcope. The application of acetic acid causes areas of abnormal 
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epithelium to turn "acetowhite”, enabling easier identification of abnormal areas.  Because 
benign changes such as squamous metaplasia and inflammation can mimic the appearance of 
dysplasia during colposcopy, suspicious areas must be biopsied to provide definitive diagnosis. 
This is a difficult, painful, and time consuming procedure often not capable of providing a 
complete diagnosis [3]. Hence, there is considerable interest in developing a non-invasive 
diagnostic tool, which can accurately identify dysplasia, follow suspicious areas over time, and 
facilitate complete excision of dysplasia and cancer by accurately delineating the margins prior 
to and during excisional surgery.  If such a screening and diagnostic program could be 
developed, it would streamline the treatment of cervical dysplasia and thus decrease the overall 
cost in the management of the disease, while also reducing patient pain and inconvenience [4]. 
 Non-invasive optical spectroscopy has been proposed as a potentially more accurate and 
cost-effective method of screening for cervical cancer. The majority of the researchers 
investigating the potential of spectroscopy to perform diagnosis in the cervix thus far has used 
autoflorescence spectroscopy either alone or in combination with other types of spectroscopy, 
including light scattering spectroscopy and diffuse reflectance [5-7]. The most extensive studies 
to date reported that fluorescence alone was able to distinguish dysplasia from non-dysplasia 
(benign areas of the cervix) with a sensitivity of 82% and specificity of 68% [8]. Trimodal 
spectroscopy, which included fluorescence, diffuse reflectance, and light scattering spectroscopy, 
improved the accuracy, separating dysplasia from benign with a sensitivity of 92% and 
specificity of 71% [5].  Research aimed at improving the accuracy of fluorescence spectroscopy 
is ongoing and focuses primarily on understanding the differences in spectral intensity due to 
menopausal status as well as the biochemical and cellular basis behind the differences seen 
between dysplastic and normal spectra [9-13]. Yet, it remains unclear if these studies will lead to 
better discrimination algorithms. 
 Raman spectroscopy is another type of optical spectroscopy which also has the potential 
to be a more accurate and cost-effective screening device than the current standard of care. 
Raman spectroscopy measures the inelastic scattering of a photon incident on a substance (the 
substance in this case is cervical tissue) [14].  Raman spectroscopy also has the potential to be 
more specific than fluorescence spectroscopy given that every molecular bond will scatter light 
with a unique shift in energy leading to a spectral fingerprint, with each peak representing a 
specific molecular bond.  Conversely, there are only a small number of molecules within tissue 
 
 
28
which will emit fluorescence upon interrogation with a specific wavelength of light. Raman 
spectroscopy has shown thus far to be a promising diagnostic tool for the discrimination of 
dysplastic and cancerous lesions in in vitro studies of the gastrointestinal tract [15], larynx [16], 
breast [17], skin [18], cervix [19], lung [20], lymph nodes [16], prostate [21], and brain [22] and 
in vivo studies of cervix [32]  esophagus [23], colon [24] skin [25], and rat carcinogenesis 
models [26] 
 Utizinger et. al. conducted a pilot study to examine the potential of using Raman 
spectroscopy in vivo for the detection of cervical dysplasia [32]. In this pilot study, Raman 
spectra were measured in vivo from 25 patients with a diagnosis of an abnormal Pap smear using 
signal collection times of 60-120 seconds. Data from 13 of those patients was used for analysis. 
The results showed specific spectral changes associated with spectra from areas of dysplasia as 
compared with spectra from areas of normal cervix and benign changes of the cervix 
(inflammation, squamous metaplasia).  A model using empirically derived peak ratios was able 
to distinguish high grade dysplasia from all others misclassifying only one spectrum. 
 Our current study was designed to follow-up on the results of the pilot study to further 
test the potential of using Raman spectroscopy to perform real-time diagnosis in vivo in the 
cervix.  Some differences in the current study include: a larger study population (79 versus 25 in 
the pilot study), more spectra measured per patient (on average of 2-6 spectra versus only 2 
spectra in the pilot study), utilization of a more clinically relevant measurement time (5 seconds 
versus 90 seconds in the original study), inclusion of a subset of "normal" subjects undergoing 
hysterectomy with no evidence of cervical disease, and utilization of an automated signal 
processing technique to produce yield more reproducible spectra. 
 The goals of  this current study are the following: to characterize the Raman spectral 
features for five different pathologic categories in the cervix (normal ectocervix, normal 
endocervix, squamous metaplasia, low grade dysplasia, high grade dysplasia), develop a 
classification model using logistic regression algorithms to separate the spectra into benign or 
dysplasia categories, give an unbiased estimate of the accuracy of spectral classification and map 
the observed spectral differences to known the biochemical and cellular origins for specific 
Raman peaks. 
 
3.3  Methods 
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 3.3.1  Study Design 
 Raman spectra from 79 patients undergoing diagnostic or therapeutic procedures to 
remove tissue from the cervix were measured in vivo prior to excision of tissue as part of two 
different studies approved by the Vanderbilt Institutional Review Board (IRB). Informed consent 
was obtained from each patient prior to the study. 
 The first study, which focused on dysplasia patients, measured spectra from 44 patients 
with a history of an abnormal Pap smear or known abnormalities of the cervix from previous 
colposcopic evaluation. Any adult, non-pregnant patient undergoing a Loop Electrocautery 
Excision Procedure (LEEP), cervical biopsy (including conization), or radical hysterectomy at 
the Vanderbilt Colposcopy Clinic or Vanderbilt Ingram Cancer Center was eligible to 
participate. Colposcopic examination of the cervix was performed first to identify normal and 
abnormal areas of the cervix. Multiple (2-6) Raman spectra of colposcopically normal and 
abnormal appearing sites were measured in vivo after the application of 4% acetic acid, but prior 
to the excision of tissue. One background measurement was made with the laser off and the fiber 
optic probe in contact with the tissue to measure the ambient light present at the tissue. 
Following spectral measurements, the measured sites then were marked with a methylene blue 
paste. The tissue was then excised according to standard clinical protocol (or in the case of 
radical hysterectomy, the hysterectomy proceeded as normal) and the histological analysis was 
performed by the participating gynecological pathologist (HS). 
 The second study focused on patients with a normal cervix undergoing total abdominal or 
vaginal hysterectomy for indications other than disease of the cervix. Raman spectra were 
measured from a total of 35 patients. To be eligible for enrollment in the study, patients were 
required to be undergoing a hysterectomy for reasons other than cervical disease, be between the 
ages of 18-75, and have a history of previous normal Pap smear or normal exam of the cervix. 
The study was performed after the patient was placed under general anesthesia but prior to the 
start of the hysterectomy. Colposcopic examination of the cervix was performed first to identify 
all colposcopically normal and abnormal (if any) appearing areas of the cervix. Colposcopy was 
performed for two reasons: to ensure the measured areas were colposcopically normal and to 
maintain consistency with the study of dysplasia patients. Three areas of normal cervix were 
identified for measurement. If the squamocolumnar junction was visible, then columnar 
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epithelium (endocervix) was chosen as one of the sites to increase the overall numbers of 
endocervix spectra in the study. Multiple Raman spectra were measured from each chosen site in 
vivo. A background measurement was made, and the sites of measurement were marked as in the 
study of dysplasia patients. The hysterectomy then proceeded according to standard clinical 
protocol.  After the hysterectomy the histological analysis of the cervical tissue specimen was 
performed by the participating gynecologist pathologist (HS). 
 Raman spectra were collected using a portable Raman spectroscopy system consisting of 
a 785 nm diode laser (Process Instruments, Inc., Salt Lake City, UT), fiber optic probe (Visionex 
Inc., Atlanta, GA), imaging spectrograph (Kaiser Optical Systems, Inc., Ann Arbor, MI), and 
back-illuminated, deep-depletion, liquid nitrogen cooled charge coupled device (CCD) camera 
 
  
CCD
NF
BP
Probe
Diode Laser
785 nm, 80 mW
7 300-µm fibers
Single 400 µm fiber
Spectrograph
Computer  
Figure  3.1: Diagram of Raman spectroscopy system used for data collection. 
Note: CCD: Charged Coupled Device, NF: notch filterat 785 nm, BP: band pass filter at 785 nm 
 
 
(Roper Scientific, Inc., Princeton, NJ) all controlled with a laptop computer.  A diagram of the 
system is shown in figure 3.1. The beam-steered fiber optic probe delivers 785 nm incident light 
onto the tissue and collects the scattered light. The collected light is then filtered with an inline 
notch filter within the probe itself. The light is then fed into the spectrograph where it is filtered 
again with a holographic notch filter and dispersed onto the CCD camera where the computer 
records the signal. For this study, the fiber optic probe delivered 80mW 785 nm incident light 
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onto the tissue and collected the scattered light for 5-15 seconds. In all cases, the overhead 
fluorescent lights and colposcope light were turned off during the measurements. Any 
luminescent lights were left on but turned away from the measurement site. 
 
3.3.2  Data Pre-Processing and Extraction 
 Prior to the spectral measurements in each patient, a spectral calibration of the system 
was performed using a neon-argon lamp and naphthalene standard to correct for system 
wavenumber, laser excitation, and throughput variations. For each Raman spectrum measured, 
the signal from the CCD camera was binned along the vertical (intensity) axis to create a single 
spectrum per measurement site. Prior to any signal processing, the spectrum was truncated to 
only include the region from 950 cm-1 to 1850 cm-1. This eliminated the large Raman peaks 
below 950 cm-1  primarily due to the silica present in the fiber optic probe that obscure any tissue 
Raman peaks and the noise present at the very end of the spectral region.  The spectrum was then 
binned along the horizontal (wavenumber) axis such that each data point represents the intensity 
from 3.5 cm-1. The spectrum was then filtered using a 2nd order Savitzky-Golay filter (window 
=17.5 cm-1) for noise smoothing [27]. Fluorescence subtraction was accomplished using a 
modified polynomial fitting method in which a 5th order polynomial is fit to the fluorescence 
baseline [28].  Following data pre-processing, each spectrum was normalized to its mean spectral 
intensity across all Raman bands to account for overall intensity variability. These normalized 
spectra were used for further comparison and analysis. 
 
3.3.3  Data Analysis 
 The processed Raman spectra were grouped according to the corresponding histological 
diagnosis for analysis (see table 3.1). 
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Table 3.1: Description of the Pathology Categories Used to Group Spectra 
PATHOLOGY CATEGORY DESCRIPTION 
Normal ectocervix Squamous epithelium 
Normal endocervix Columnar epithelium 
Squamous metaplasia Benign change of cervical 
epithelium from columnar to 
squamous 
Low grade dysplasia Cervical Intraepithelial Neoplasia I 
(CIN I), HPV changes 
High grade dysplasia CIN II/III, carcinoma in situ (CIS), 
invasive squamous cell carcinoma 
 
 
Data from 11 dysplasia patients were excluded from analysis for one of the following reasons: 
instrument malfunction, low signal to noise ratio, inability to obtain accurate histological 
diagnosis, or excessive room light that obscured the Raman spectra. Data from 2 normal patients 
were excluded due to low signal to noise or camera saturation. Thus, data from a total of 66 
patients (33 dysplasia patients, 33 normal patients) were used in this analysis. If multiple spectra 
were collected from a single location within a given patient, only the first spectra collected was 
included for data analysis. 
 The mean and standard deviation of the spectra within each pathology group were 
calculated to characterize the overall spectral trends for each pathology group.  A student’s t-test 
was performed at each wavenumber between individual pairs of pathology groups to help 
identify regions of spectral distinction between two different pathologies. 
 The classification model was constructed to automatically classify spectra into one of two 
categories (high grade dysplasia or benign cervix) using two-tiered logistic regression model 
[29]. The process to develop the model is diagrammed in chart 3.1. Traditional linear regression 
fits an equation of a line to model a set of data. Yet linear regression does not work well when 
attempting to model data with discrete outcomes. Logistic regression overcomes this problem by 
using a non-linear transformation of the traditional linear regression such that the solution of the 
algorithm is restricted to values between 0 and 1 (eq. 3.1).   
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)()
1
ln( inputsba
score
score ×+=−     (eq. 3.1) 
where  a = residual constant as determined by model fit 
 b = array of model coefficients 
 score = model score/probability for model inputs belonging to high grade  
  dysplasia category 
 
 The logistic regression algorithms used in the model described here were trained using 
the glmfit function and tested using the glmval function in MATLAB® R12. In training of the 
algorithm, the algorithm coefficients (b) and residual constant (a) are derived by determining a 
best of the training set inputs and their corresponding assigned scores (assigned by the user). The 
first algorithm was trained to classify a spectrum as either normal ectocervix (score=0) or high 
grade dysplasia (score =1) and was developed using independent training and validation sets that 
were randomly generated by dividing the normal ectocervix and high grade dysplasia data sets 
into a training set (two-thirds of the patients) and a validation sets (one-third of the patients).  
Any major peak that showed statistical difference at the level of p< 0.01 between normal 
ectocervix spectra and high grade dysplasia spectra was chosen as an input for the algorithm. 
Thus, the inputs to the algorithm are the normalized intensity values at 1006, 1058, 1240 1305 
1324, 1450, 1550, 1655 cm-1 (see figure 3.3) and the logistic regression equation is as shown in 
equation 3.2.  
16558155071450613245
13054124031055210061)1
ln(
IbIbIbIb
IbIbIbIba
score
score
∗+∗+∗+∗+
∗+∗+∗+∗+=−   (eq 3.2) 
 
 The algorithm outputs a score which represents the probability that the input represents 
high grade dysplasia.  Data from the other pathology categories (normal endocervix, squamous 
metaplasia, and low grade dysplasia) were also included as part of the test set for the model even 
though no data from these categories were included in the training set to examine the possibility 
that a single algorithm could discriminate all spectra of benign pathology from dysplasia spectra 
(see discussion). Since the specificity of this one algorithm model was less than desired due 
primarily to misclassifications of squamous metaplasia spectra, a second logistic regression 
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algorithm developed to separate high grade dysplasia from squamous metaplasia was developed 
to increase the specificity of the overall model.  
 The second algorithm was trained with all high grade dysplasia (score=1) and squamous 
metaplasia (score=0) spectra. The same inputs used in the first algorithm are also used as inputs 
in the second algorithm, but the output is a value (score) which represents the probability that the 
spectra was measured from an area of high grade dysplasia as compared with squamous 
metaplasia. Thus, the algorithm is also represented by equation 3.2, but the coefficients (b1-8) 
are different than those in the first algorithm. Any spectra from the original test set with a score 
from the original algorithm of score>0.5 was automatically used to test the second algorithm.  
Since there were not enough spectra to create a separate training and validation sets, the 
algorithm was trained with all of the available high grade dysplasia and squamous metaplasia 
spectra, thus some of the spectra in the test set were also used to train the algorithm. 
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Scattered Data Light Pre-processing Collected & Extraction 
  
Chart 3.1: From Collection of Spectrum to Generation of First Algorithm 
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Chart 3.2 Generation of Second Algorithm
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 3.4  Results 
 The mean spectra for each pathology category are shown in figure 3.2. The most 
consistent peaks are labeled and found at 1006, 1058, 1086, 1244, 1270, 1324, 1450, 1550, 1655 
cm-1. These peaks are found in all the patient spectra.  
 
 
 
Figure  3.2: Mean Raman spectra of all pathology categories. 
The mean ± one standard deviation spectra are plotted for each pathology category. N= number of spectra. 
 
 
 Although the peak shapes and locations show consistency across all pathology 
classifications, there are small but significant differences in peak intensities between the different  
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Figure  3.3: Spectra Comparison: High Grade 
Dysplasia vs. Normal Ectocervix. 
(a) Mean spectra overlay of high grade dysplasia 
(n=29 spectra) and normal ectocervix (n=100 
spectra), (b) results of t-test at each wavenumber 
(Note: y-axis is 1-p). 
 
Figure  3.4: Spectra Comparison: High Grade 
Dysplasia vs. Squamous Metaplasia. 
(a) Mean spectra overlay of high grade dysplasia 
(n=29 spectra) and squamous metaplasia (n=29 
spectra), (b) results of t-test at each wavenumber 
(Note: y-axis is 1-p). 
 
 
pathology categories as are shown in figures 3.3-3.5 and tables 3.2-3.3. The spectral differences 
between high grade dysplasia and normal ectocervix spectra (figure 3.3) and high grade 
dysplasia and squamous metaplasia spectra (figure 3.4) are illustrated with a mean spectral 
overlay which displays the visual spectral differences and a plot of the corresponding results of t-
tests performed at each individual wavenumber. These two spectral comparisons are highlighted 
to denote that these categories were used in developing the discrimination algorithms.  
 Looking at the normal ectocervix/high grade dysplasia spectral comparison, several 
spectral regions, including 1006, 1055, 1305-1330, and 1450 cm-1, show statistical significance 
at p< 0.001 and several more peaks that show significance at p< 0.01 including 1550 and 1655 
cm-1. The comparison of squamous metaplasia and high grade dysplasia spectra in figure 3.4 
shows fewer regions of statistical difference. There are no regions which show significance at 
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p<0.001, but several peaks show significant differences at the level of p< 0.01, including 1058, 
1244, and 1550 cm-1. Although there is a difference at the 1324 cm-1 peak, it does not vary 
significantly.  While there is a valley at 1305 cm-1 in the normal ectocervix spectra, the same 
region is flat in the spectra of the squamous metaplasia, and in comparison with the high grade 
dysplasia spectra, the difference is less significant than that of the normal ectocervix/high grade 
dysplasia spectral comparison. The 1450 and 1655 cm-1 peaks, which were also significantly 
different between the normal ectocervix and high grade dysplasia spectra, do not show a visual 
or statistical difference between the squamous metaplasia and high grade dysplasia spectra. 
 
 
 
Figure  3.5: Comparisons of Mean Spectra.  
Mean spectra overlays for the following categories: (a) high grade dysplasia (n=29 spectra) and low grade dysplasia 
(n=6 spectra), (b) normal endocervix (n=8 spectra) and high grade dysplasia, (c) normal ectocervix (n=100 spectra) 
and normal endocervix, (d) low grade dysplasia and normal endocervix, (e) low grade dysplasia and normal 
ectocervix, (f) low grade dysplasia and squamous metaplasia (29 spectra). 
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 Spectral comparisons of the remaining pathology categories are shown in figure 3.5.  
Although there are only 6 low grade dysplasia spectra in the analysis, some interesting trends are 
shown in the mean overlay plots seen in figure 3.5a, d, e and f.  In panel e, the low grade 
dysplasia spectra shows an increase in the 1324 cm-1 peak as compared with normal ectocervix 
which is similar to the high grade dysplasia/normal ectocervix spectral comparison (figure 3.3). 
Yet the intensity of 1272 cm-1 peak in the low grade dysplasia spectra seems to remain similar to 
that seen in normal ectocervix, unlike in the high grade dysplasia spectra, where the peak is 
lower when compared with the spectra of normal ectocervix.  Similarly, the 1450 cm-1 peak in 
the low grade dysplasia spectra also shows little deviation from that same peak in the normal 
ectocervix spectra, unlike the significant difference seen at 1450 cm-1 in the high grade 
dysplasia/normal ectocervix spectral comparison. The comparison of the low grade dysplasia 
with squamous metaplasia spectra shows few differences; the one exception is the area from 
1300-1330 cm-1.  There is a large valley at 1305 cm-1 and subsequent peak at 1324 cm-1 in the 
low grade dysplasia spectra, whereas the squamous metaplasia spectra is relatively flat in that 
region, showing no real change from 1300- 1330 cm-1.  Unlike the comparisons of high grade 
dysplasia with normal ectocervix and squamous metaplasia spectra, the comparison of high 
grade dysplasia with normal endocervix spectra in figure 3.5b shows similarities in the intensity 
at 1324 cm-1 between the two categories. Yet, the high grade dysplasia spectra shows a decrease 
in intensity at the 1272 cm-1 peak, a change also seen in the comparisons with normal ectocervix 
and squamous metaplasia spectra.  The normal endocervix spectra also seems to retain the valley 
seen at 1305 cm-1 similar to the normal ectocervix spectra but unlike the squamous metaplasia 
case. The 1006 cm-1 peak shows an increase in the high grade dysplasia spectra, a change also 
seen when compared with the normal ectocervix spectra.  A comparison of normal endocervix 
and ectocervix spectra shows some striking differences.  Most notably, there is an increase in the 
1272 and 1324 cm-1 peaks in the endocervix spectra as compared with ectocervix spectra while 
the 1450 cm-1 peak shows a decrease in intensity. There is also a significant difference in the 
shoulder ~1100 cm-1 and the valley at 1400 cm-1.  All of the aforementioned spectral differences 
are diagrammed in tables 3.2 and 3.3. 
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Table 3.2: Spectral Changes Seen Between High Grade Dysplasia and Other Pathologies. 
The arrow represents the direction of the change in spectral intensity at that peak 
(location shown in cm-1). Statistically significant differences (p<0.01) are denoted with a larger arrow. 
High Grade Dysplasia 
vs. 1006 1058 1083 1244 1272 1305 1324 1450 1550 1657
Normal 
Ectocervix 
↑ ↓ ↔ ↓ ↓ ↑ ↑ ↓ ↑ ↑ 
Normal 
Endocervix 
↑ ↔ ↔ ↔ ↓ ↑ ↔ ↔ ↔ ↔ 
Squamous 
Metaplasia 
↑ ↓ ↔ ↓ ↓ ↑ ↑ ↔ ↑ ↔ 
Low Grade 
Dysplasia 
↔ ↔ ↔ ↔ ↓ ↑ ↔ ↑ ↔ ↔ 
 
 
Table 3.3: Spectral Changes Seen Between Low Grade Dysplasia and Other Pathologies. 
The arrow represents the direction of the change in spectral intensity at that peak 
(location shown in cm-1). Statistically significant differences (p<0.01) are denoted with a larger arrow. 
Low Grade Dysplasia 
vs. 1006 1058 1083 1244 1272 1305 1324 1450 1550 1657
Normal 
Ectocervix 
↔ ↓ ↑ ↓ ↑ ↔ ↑ ↔ ↔ ↔ 
Normal 
Endocervix 
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↑ ↓ ↔ 
Squamous 
Metaplasia 
↔ ↔ ↔ ↔ ↑ ↔ ↑ ↔ ↔ ↔ 
 
 
 Figure 3.6a shows the results from the test set as scored by the first algorithm developed 
to distinguish high grade dysplasia from normal ectocervix.   
 
 
42
ab
 
Figure  3.6: Model Classification of Test Set.  
(a) model scores for first unbiased algorithm (b) model scores for second algorithm, all spectra with model score of 
p>0.5 in the first algorithm were used as inputs to second algorithm 
 
 
Each data point represents an individual spectrum from the independent test set.  The spectra are 
grouped along the x-axis by pathology classification as determined by histological examination, 
and the corresponding model score is shown on the y-axis.  The line drawn at y=0.5 represents 
an unbiased model separation of high grade dysplasia (y>0.5) from normal ectocervix (y<0.5).  
The model classifies 8 out of 9 high grade spectra and 31 out of 35 normal ectocervix spectra 
correctly. The figure also illustrates the results from the model classification of the remaining 
three pathology types (normal endocervix, squamous metaplasia, low grade dysplasia). Although 
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the model was not trained with spectra from these pathology categories, an attempt to classify 
these spectra using this model was made based on the premise that normal ectocervix and high 
grade dysplasia represent the extremes of pathology within the cervix. The majority of the 
normal endocervix spectra classify as normal (score<0.5) which is promising for separating 
normal endocervix from high grade dysplasia. The scores for the majority (4 out of 6) of the low 
grade dysplasia spectra cluster around score=0.5 which would be expected as low grade 
dysplasia represents an intermediate from normal to high grade dysplasia.  The scores from the 
squamous metaplasia spectra lack any definitive pattern of classification.  Although squamous 
metaplasia represents a benign change of the cervix, using the initial algorithm, 8 out of 29 
spectra classify as high grade dysplasia.  Based on these observations, a second algorithm to 
further distinguish between squamous metaplasia and high grade dysplasia was developed to 
enhance the specificity of the model when distinguishing high grade dysplasia from all benign 
areas of the cervix. 
 The second algorithm is also a logistic regression based algorithm, trained to distinguish 
between squamous metaplasia and high grade dysplasia. Figure 3.6b shows the results of this 
model classification.  This second algorithm is able to correctly classify 5 out of 8 squamous 
metaplasia spectra and all of the high grade dysplasia spectra. Again, since all spectra from the 
original test set with a mode score>0.5 were used as inputs to the second algorithm, some normal 
ectocervix and endocervix and low grade dysplasia spectra from pathology categories were 
included in the test despite the fact that those pathologies were not used in the training of the 
model.  Among these, 3 out of 4 of the normal ectocervix spectra, none of the low grade 
dysplasia spectra, and 1 out of 3 of the normal endocervix classified as high grade dysplasia. 
 Comparisons of the accuracy of the model classification (with and without the second 
algorithm) are shown with the corresponding results of the accuracy of the colposcopic diagnosis 
as recorded in the clinical studies in table 3.4.  Results from low grade dysplasia and normal 
endocervix are not included in the calculations of accuracy due to the fact that these categories 
were not included in the training algorithms. Thus the computed accuracies shown in table 3.4 
compare only normal ectocervix and squamous metaplasia with high grade dysplasia. The 
colposcopic results were also computed only for diagnoses of normal ectocervix, squamous 
metaplasia, or high grade dysplasia. 
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Table 3.4: Accuracy of Classification. 
The accuracy of the model classification are compared with the accuracy of the physician colposcopic diagnosis. HG 
dysplasia=high grade dysplasia. Note: italicized columns represent results from a biased estimates of accuracy. 
HG dysplasia vs. Benign (normal 
ectocervix + squamous metaplasia 
HG dysplasia vs. 
Normal ectocervix 
HG dysplasia vs. 
squamous metaplasia 
 
Model 
algorithm 1 
Model 
algorithms 
1+ 2 
Colposcopy 
Model 
algorithm 
1 
Colposcopy 
Model 
algorithms 
1 + 2 
Colposcopy 
Sensitivity 89% 89% 87% 89% 89% 89% 97% 
Specificity 81% 88% 72% 89% 88% 90% 8% 
 
 
3.5  Discussion 
 This study represents the next step in developing Raman spectroscopy as a potential tool 
in the screening and diagnosis of cervical dysplasia and cancer. Many improvements over the 
pilot study investigating the potential of using Raman spectroscopy for diagnosis in the cervix 
have been made in this study [32].  The system used in this study, diagrammed in figure 3.1, 
allows collection of high quality spectra with a much lower signal collection time (5 seconds 
versus 60-1200 seconds in the pilot study) [32].  The use of automated signal processing methods 
yields more reproducible spectra than the pilot study [28]. In the pilot study, peak locations 
varied with standard deviations ranging from 7.5 – 35 wavenumbers whereas the peak locations 
in this study vary with a standard deviation of less than 5 wavenumbers . These two advances, 
coupled with robust discrimination algorithms, make it feasible to develop a system to provide 
real time diagnosis in the clinic or operating room. 
 Results from the model classification show that Raman spectroscopy in combination with 
an logistic regression algorithm can distinguish between high grade dysplasia and benign areas 
of the cervix (normal ectocervix, squamous metaplasia) with similar sensitivity and higher 
specificity using unbiased estimates of accuracy when compared to colposcopy.  Logistic 
regression provides a particularly powerful approach to the task of classifying spectra into 
pathologic categories.  Since the output of the model is a value (score) which represents the 
percentage likelihood that a spectrum falls into one of two categories, the model not only can be 
used to classify the spectra, but also used to aid health care providers in quantifying and 
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following the disease of the patient over time.  This type of score also enables the provider to use 
his or her knowledge from the clinical examination in combination with the information given by 
the model to derive a diagnosis for each individual patient rather than rely solely on a computer 
model to generate a diagnosis. 
 The model presented here is a preliminary formulation designed to estimate the ability of 
Raman spectroscopy to perform pathologic classification of individual spectra on a larger scale. 
Even though multiple spectra were sometimes collected from the same site in a particular patient, 
only one spectra was used per location within a given patient for the data analysis. The first 
spectra collected at each site was used in lieu of average spectra to best predict the ability of 
Raman spectroscopy to perform diagnosis on a single spectrum. This prevents an overestimation 
of the accuracy predictions. If only the first algorithm of the model is used, the estimates of 
model accuracy are completely unbiased and therefore, statistically should perform equally as 
robust on future data sets. Since the second algorithm of the model contains some of the same 
data in both the training and test sets, performance estimates are biased, and thus cannot be used 
to predict future accuracy.  Although the model performs well when compared with the standard 
of care (colposcopy) (see table 3.4), further testing of the second algorithm is necessary in the 
form of an independent validation set of data to clarify the future performance of the second 
algorithm. Yet, developing this two tiered model allows the ability to predict the type of 
algorithm or series of algorithms that are likely to successfully classify the data for future model 
development. 
 Intensity values from eight of the major Raman spectral peaks were chosen as inputs for 
the model based on results of t-tests between spectra of different pathologies. By only using 
those peaks which showed statistically significant differences, the model inputs represent 
spectral areas which show potential for future algorithm development. Analysis of the correlation 
between model coefficients indicated that no two model inputs are highly correlated (i.e. r>0.75). 
This ensures that there are no redundant model inputs. Yet, future development may be able to 
reduce the number of model inputs.  
 Though a model could have been constructed with multiple algorithms to classify each 
pathology category individually using a leave one out method, doing so would not give a true 
estimate of the future accuracy of such algorithms.  Since so few low grade dysplasia and normal 
endocervix spectra were available for analysis, we chose to not attempt to train a separate 
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algorithm to specifically classify these categories. Their inclusion in the testing of the model was 
done as an exploratory process, not for the purposes of assessing accuracy. A multiple algorithm 
model may prove to be even more accurate at classifying spectra from these pathology 
categories. 
 Although the low grade dysplasia and normal endocervix spectra were not included in 
training of the model, the results from their inclusion in the test set show definite trends of 
classification (figure 3.6). Using only the first algorithm, the majority (5 out of 8) of the normal 
endocervix spectra  classify with the normal ectocervix spectra, and while promising, it indicates 
the need for a separate algorithm to distinguish endocervix from dysplasia spectra. When placed 
in the second algorithm, an additional 2 out of 3 of the normal endocervix spectra classified with 
the squamous metaplasia spectra (or “benign”) bringing the overall classification of endocervix 
spectra as benign to 7 out of 8. The classification of low grade dysplasia spectra using the first 
algorithm shows that the model scores for 4 out of 6 low grade dysplasia spectra cluster between 
0.4-0.75. This finding could result from the fact that low grade dysplasia is an intermediate stage 
in the progression of normal ectocervix to high grade dysplasia, and thus the low grade dysplasia 
would classify in the middle. Thus, it is possible that a single algorithm would be able to separate 
normal cervix, low grade dysplasia, and high grade dysplasia with the accumulation of a larger 
training and test set of data. A true estimate of the ability of a model can only occur with a larger 
data set and an increase in the numbers of low grade dysplasia and normal endocervix spectra. 
 It is encouraging that the most significant spectral differences of all of the pathology 
comparisons are seen in the normal ectocervix/high grade dysplasia spectral comparison.  
Because normal ectocervix and high grade dysplasia represent the two extremes of a continuum 
of the development of neoplasia, they have more biochemical and morphological difference than 
any other categories, which would theoretically lead to differences in the Raman spectra.  These 
two groups also have the highest number of spectra of any of the categories, and thus, significant 
differences are more likely to be detected when present. The results from the model classification 
of high grade dysplasia and normal ectocervix using the first algorithm also are encouraging 
(figure 3.6). The discrimination line at p=0.5 was used to ensure that the estimates of algorithm 
accuracy were completely unbiased. Yet, if the discrimination line is drawn at 0.75, the 
specificity of the discrimination increases to 100% while only misclassifying one additional high 
grade dysplasia case, although this would bias the classification on the test set.  A future 
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independent validation set of data could test whether a discrimination line at 0.75 would truly 
yield better results.   It should be noted that 3 of the spectra in the high grade dysplasia test set 
have a histological diagnosis of invasive squamous cell carcinoma, although no invasive 
carcinoma spectra were used in the training of the algorithms. These spectra were classified by 
the model as high grade dysplasia as would be expected. Their inclusion in the test set indicates 
that although the algorithm was trained to recognize high grade dysplasia spectra, it will also 
correctly identify more severe pathologies.  Of all the categories, squamous metaplasia was the 
only category not exhibiting any trends of classification using the first algorithm (figure 3.6a).  
This result is not surprising given that although dysplasia often originates in the context of 
squamous metaplasia, squamous metaplasia results from a different process of tissue 
transformation than dysplasia.  Although the second algorithm improved the classification of the 
squamous metaplasia spectra (figure 3.6b), the spectral differences between squamous 
metaplasia and high grade dysplasia are subtle, and thus generating more robust classification 
algorithms will likely require large numbers of spectra. 
 The differences seen between the mean spectra of high grade dysplasia and normal 
ectocervix correlate well with the differences observed using an organotypic raft culture model 
(figure 3.3) [30].  In these experiments, in vitro tissue cultures that mimic in vivo conditions of 
cervical tissue were grown and analyzed using Raman spectroscopy.  The results from raft 
culture experiments indicate that the 1324 cm-1 peak arises primarily from the epithelial layer of 
tissue [30]. This finding is in agreement with previous studies which assigned the region 
surrounding 1330 cm-1 to the purine bases in the nucleic acid of epithelial cells as evidenced by 
confocal measurements of skin epithelium and classical Raman spectroscopy peak assignment 
[15, 18, 31]. In contrast, the 1272 cm-1 is an Amide III peak and arises primarily from the type I 
collagen in the stromal layer of the tissue [30, 31].  Thus, the changes seen in the spectra of high 
grade dysplasia reflect changes in the structure and biology during the transformation from 
normal to dysplasia.  The increase seen at 1324 cm-1 in the high grade dysplasia spectra is most 
likely due to the increase in the cellular and nucleic acid content in dysplasia while the decrease 
at 1272 cm-1 likely reflects a decrease in the light collected from the stromal layer due to the 
increase in density (and thus decrease in transparency) of the epithelial layer. The 1450 and 1655 
cm-1 peaks have contributions from both the epithelial and stromal layers [30]. The 1450 cm-1 
peak is traditionally thought to arise from the C-H stretch in lipids whereas the 1657 cm-1 peak is 
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an amide I peak [15]. Since the 1657 cm-1 peak has origins in the epithelial and stromal layers, it 
likely arises from a bond common to both collagen and cellular proteins, and likely has 
contributions from the keratin [18, 30]. The origins of the peaks at 1244 and 1305 cm-1 are less 
clear although 1244 cm-1 is often included in the amide III region; both peak intensities are 
significantly different in the high grade dysplasia/normal ectocervix and high grade 
dysplasia/squamous metaplasia spectral comparisons (figures 3.3, 3.4). Although the majority of 
the peak centered at 1070 cm-1 is due to the Raman scatter of the silica in the fiber optic probe, 
the smaller peaks at 1055 and 1083 cm-1 likely arise from the tissue [31]. The peak at 1083 cm-1 
has been shown to arise from acyl backbone in lipids. The 1006 cm-1 is known to arise from 
phenylalanine and the source of 1550 cm-1 is thought to be tryptophan [15]. Future studies will 
establish the origins of these peaks in a more definitive manner. 
 These results show that Raman spectroscopy, in conjunction with a model developed 
using logistic regression algorithms, can distinguish high grade dysplasia from normal ectocervix 
and squamous metaplasia with a similar sensitivity and higher specificity than colposcopy 
performed by experts. Future clinical studies are needed to increase the numbers of spectra, 
especially in the low grade dysplasia and normal endocervix categories, such that independent 
training and test sets can be used to develop more effective algorithms and further discriminate 
all pathology categories. 
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4.1  Abstract 
 Raman spectroscopy has the potential to provide non-invasive, real-time differential 
diagnosis of different pathologies in the cervix. Yet the sources and relative contributions of 
spectral variability for a given pathology must be understood to accurately predict whether 
Raman spectroscopy can be an effective method for screening for cervical cancer. This study 
seeks to understand and quantify the sources of variance within spectra of normal ectocervix. 
 For this study, Raman spectra were collected in vivo from 35 patients with no evidence of 
cervical dysplasia who were undergoing hysterectomy for indications other than cervical disease. 
Data from the first five patients was used to determine the optimal signal collection time. Data 
from the next two patients in addition to data from a concurrent study of dysplasia patients 
examined the effect of the application of acetic acid on the spectra. The remaining patient studies 
were used to quantify the spectral variance arising from within a site, within a patient, and 
between different patients. Further analysis of the sources of interpatient variability examined the 
spectral differences due to menopausal status, smoking history, and overall patient diagnosis 
(normal from normal patients vs. normal from dysplasia patients).  
 The optimal signal collection time was determined to be five seconds. The acetic acid 
analysis showed two small, non-significant spectral changes arising after the application of acetic 
acid; no time dependant changes were noted. Interpatient variability was found to be the main 
source of variability within normal ectocervix, contributing 73% of the total variance. Significant 
spectral differences were found between pre-menopausal and post-menopausal normal spectra as 
well as between normal spectra from normal patients and normal spectra from dysplasia patients. 
Spectral differences between smokers and non-smokers was negligible. The analyses presented 
here improve the understanding of the sources of variation within a given pathology and will aid 
the future development of discrimination algorithms for the detection of cervical dysplasia. 
 
4.2  Introduction 
 In recent years, optical spectroscopy has been the focus of several groups as a modality 
for accurate, real time diagnosis of cancer and precancerous lesions [1, 2]. Among these, Raman 
spectroscopy is a novel, molecular specific technique that has been shown to have the potential 
for providing differential diagnosis in the gastrointestinal tract [3], larynx [4], breast [5], skin [6], 
cervix [7], lung [8], lymph nodes [9], prostate [10], and brain [11]. Previous in vivo studies 
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investigating the potential of using Raman spectroscopy for non-invasive detection of dysplasia 
(precancer) in the cervix showed that Raman spectroscopy can distinguish high grade dysplasia 
from all other pathologies using empirically determined peak ratios [21]. Since spectral 
measurements and analysis can be done in real time, Raman spectroscopy also has the potential 
to be a more cost effective means of screening, diagnosis, and guidance of therapy. 
 Preliminary data analysis from an ongoing clinical study examining the ability of Raman 
spectroscopy to detect cervical dysplasia indicates that a non-trivial amount of spectral variation 
exists between different spectral measurements of the same tissue pathology [12]. In order to 
understand and predict whether Raman spectroscopy can be an effective method for screening 
for cervical cancer, the origins and relative contributions of the sources of this variation must be 
understood.  Such an understanding could lead to better design of clinical trials, rational design 
of automated algorithms for real time diagnosis, and better prediction of the potential of Raman 
spectroscopy to accurately perform diagnosis within the general population.  
 In examining sources of variation of Raman spectra measured from normal skin, 
Knudsen et. al. looked at variations due to time lapse (spectra measured at different times during 
the day as well as day to day variations), different locations within the body, different 
measurements at the same location, and different persons in 13 volunteers as well as variations 
due to skin pigmentation which was studied in 140 volunteers [13]. The variability was 
quantified by comparing relative intensities of peaks; small differences were found in the overall 
spectral intensity (affected by differences in skin pigmentation), the amide I peak (intersubject 
and between subsequent measurements), and the amide III peak (diurnal and intersubject).  
Numerous studies using fluorescence spectroscopy in the cervix have looked at different sources 
of intrapatient and interpatient variability including menopausal status, menstrual cycle 
variations, age, smoking history, the application of acetic acid, and overall diagnosis of the 
patient (comparing normal spectra from normal patients with normal spectra from dysplasia 
patients)[14-17]. Yet, none of these studies have quantified the contributions of variance from 
individual sources to the overall variance.    
 Thus, this study was designed to examine and quantify the sources of the intrinsic 
spectral variation observed in vivo. Raman spectra were measured from the normal cervix of 
women undergoing hysterectomy for reasons other than cervical disease.  The amount of spectral 
variation was quantified for the following categories: within the same site (intrasite), between 
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different locations in the same patient (intrapatient), between different patients (interpatient), and 
instrinsic measurement variation. The contributions of potential sources of interpatient variation 
were examined including: menopausal status, smoking history, and overall patient diagnosis.  
The application of acetic acid was studied as a possible source of intrapatient variation, and the 
optimal length of time for collecting signal was quantified.  By examining the contributions of 
these sources of variation, a deeper understanding of how these variations affect tissue 
spectroscopic diagnosis is achieved. 
 
4.3  Methods 
 
4.3.1  Clinical Study Design 
 Thirty-five patients undergoing total abdominal or vaginal hysterectomies were recruited 
to participate in the study as approved by the Vanderbilt Institutional Review Board (IRB). To be 
eligible for enrollment in the study, patients must be undergoing a hysterectomy for reasons 
other than cervical disease, between the ages of 18-75, and have a history of previous normal 
Papanicolaou (Pap) smear or normal exam of the cervix. Informed consent was obtained from 
each patient prior to the procedure. After the patient was placed under anesthesia, but before the 
hysterectomy procedure began, a colposcopic examination of the cervix under anesthesia was 
performed and the Raman spectral measurements were collected. Five percent acetic acid was 
swabbed on the cervix to visually enhance any abnormal areas of epithelium. Colposcopy was 
performed for two reasons: to ensure the measured areas were colposcopically normal and to 
maintain consistency with a concurrent study of dysplasia patients [12]. Multiple Raman spectra 
of colposcopically normal appearing sites then were measured in vivo. One background 
measurement was made with the laser off and the probe in contact with the tissue to measure the 
ambient light present at the tissue. The measured sites were marked with a methylene blue paste. 
The hysterectomy procedure then proceeded according to standard clinical protocol. Upon 
removal of the cervix, histologic analysis was performed by the participating gynecological 
pathologist (HS). 
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4.3.2  Data Collection 
 Spectral measurements were collected using the portable Raman spectroscopy system 
described in chapter 3. For this study, the fiber optic probe delivered 80mW 785 nm incident 
light onto the tissue and collected the light. The signal collection time varied between 1-15 
seconds depending on the protocol under study (table 4.1). In all cases, the overhead fluorescent 
and colposcope lights were turned off during the measurements. Any luminescent lights were left 
on but turned away from the measurement site.  
 The spectral measurements followed one of three protocols (table 4.1). Studies on the 
first five patients were designed to determine the optimal signal collection time. In these patients, 
three sites on the cervix were chosen.  Five spectra were acquired at each site, each using a 
different signal collection time (1, 3, 5, 8 seconds, or 3 accumulations of 5 seconds for a total of 
15 seconds).  The fiber optic probe was kept in contact with the tissue throughout the five 
measurements at each individual site. Studies on another 2 patients examined the affect of 
applying acetic acid to cervix. These patients were a part of a larger analysis ongoing with a 
concurrent study of dysplasia patients [12].  In this study, three sites were again chosen for 
measurements.  All spectra were collected using a 5 second signal collection time. Spectra were 
acquired at each site prior to the application of acetic acid and at various time intervals ranging 
from 0-180 seconds following the application of acetic acid to determine the effect, if any, of 
acetic acid on the Raman spectra. Studies on the remaining study subjects (subjects 8-35) were 
designed to examine the sources of variation.  In this final study, three sites were chosen for 
measurements (as in the other protocols); 3 spectra were collected at each site: the first two were 
collected without moving the fiber optic probe, and the last was acquired after removing the 
probe and replacing it at the same site.  This allowed for determination of the relative variability 
due to user error of probe placement versus intrinsic variability of the Raman spectra. The 
measurements at different locations within the normal ectocervix of a given patient allowed for 
the calculation of variation due to location variability, and the comparison of spectra between 
different patients allowed for the calculation of variation arising from interpatient variation. 
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Table 4.1: Details of Different Measurement Protocols 
Patient # Signal 
Collection 
Time 
# sites 
measured 
# measurements per site 
1-5 1,3, 5, 8, 15 
seconds 
3 5: one for each signal collection time 
6-7 (plus 5 
patients from 
dysplasia study) 
5 seconds 3 4: relative to application of acetic acid 
(1) before, (2) 30-60 sec after 
(3) 60-90 sec after (4) 90+ sec after 
8-35 5 seconds 3 3: 2 made without moving the probe, 1 made after 
removing the probe and placing back on the same site. 
 
 
4.3.3  Data Pre-Processing and Extraction 
 Prior to the spectral measurements from each patient, a spectral calibration of the system 
was performed using a neon-argon lamp and naphthalene standard to correct for system 
wavenumber, laser excitation, and throughput variations. The spectra were processed as 
described in chapter 3. Following data processing, each spectrum was normalized to its mean 
spectral intensity across all Raman bands to account for overall intensity variability. These 
normalized spectra were categorized according to pathology as determined by histology and used 
for further comparison and analysis. If multiple spectra were collected from a single location 
within a given patient, only the first spectra collected was included for data analysis. 
 
4.3.4  Data Analysis 
 To estimate the optimal integration time, the signal to noise ratio was calculated for each 
spectra collected at the different measurement times (1, 3, 5, 8, and 15 seconds) for the first five 
patients. An automated routine was developed to extract the level of signal (intensity at 1450 cm-
1 peak) and the noise (largest intensity for region surrounding 1700 cm-1) from the unfiltered 
spectra (each spectrum was binned along horizontal axis and the fluorescence background was 
subtracted, but the spectrum was not smoothed with any filter).   
 The effect of acetic acid on the Raman spectra was analyzed using a mean spectral 
overlay and student’s t-test to compare the spectral variability at each wavenumber of spectra 
collected from areas of dysplasia before and after the application of acetic acid. This effect was 
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further quantified by calculating the spectral difference between individual spectra measured 
before and after the application of acetic acid at a specific site.  The spectral difference was 
defined as the difference in intensity between the zero time point (no acetic acid) and various 
time points after the application of acetic acid at the 10 major peaks in the spectra (1006, 1058, 
1083, 1244, 1272, 1305, 1324, 1450, 1550, 1657 cm-1).  The mean (across the ten peaks) of these 
intensity differences was calculated (such that one mean spectral difference was calculated for 
each spectrum) and used for the analysis. 
 The variability due to probe placement also was quantified by calculating the mean 
spectral difference (as described above) between an initial measurement and a subsequent 
measurement in which the probe was either kept in place or removed and replaced at the initial 
site.  The remaining components of variance were calculated using analysis of variance 
(ANOVA) and Henderson’s method [18]. Henderson’s method estimates the variance due to 
each component by setting its observed mean squared error (MSE) from the ANOVA table equal 
to its expected value which can be represented as linear combinations of the variance 
components. The equations used for this analysis from Henderson’s method are shown below in 
equations 4.1- 4.14 and were encoded for automatic calculation into MATLAB® R12.         
The following calculations were done for each wavenumber in the spectrum: 
 
 
First calculate the SS = "SUM OF SQUARES" for each category (of variability) for use in the 
ANOVA table: 
 
ss(patients) = ( ) Cny ii
i
−+++∑ /2     (eq. 4.1) 
where  
   = C ( ) +++++ ny /2         (eq. 4.2) 
ij
j
i nn ∑=+  = # observations for patient  i
ijk
jk
i yy ∑=++  = sum of intensity for patient i  
ij
ji
nn ∑=++
,
 = total number of observations  
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ijk
kji
yy ∑=+++
,,
 = grand sum 
 
 
ss(location) = ( ) ( )++++ ∑∑∑ − ii
i
ijij
ji
nyny // 22    (eq. 4.3) 
where 
ijn  = # observations for patient i at location  j
ijk
k
ji yy ∑=+ = sum of intensity for patient i  at location  j
 
ss(meas. error) = ( )ijij
ji
ijk
kji
nyy /22 +∑∑∑∑∑ −   (eq. 4.4) 
where 
ijky = intensity for the  th measurement for patient i  at location  k j
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Now, the ANOVA table can be constructed 
 
Component Degrees of freedom SS 
Mean Squares 
(MS) 
Expected Vaule of MS 
(E<MS>) 
PATIENTS 
(interpatient) 1−P  ss(patients) 
ss(patients) 
 2
2
2
1
2
P
L
C
C
σ
σσ
+
+Σ  
LOCATION 
(intrapatient) PL −  ss(location) 
ss(location) 
 
2
3
2
LC σσ +Σ  
ERROR 
(intrinsic 
spectral 
variability) 
 
Ln −++  ss(meas. error) 
ss(meas. error) 
 
2
Σσ  
1−P
PL −
Ln −++
 
where: 
P = Total # of patients 
L = Total # of locations measured 
2
Σσ  = variance due to intrinsic measurement error 
2
Lσ  = variance due to location variability 
2
Pσ  = variance due to patient variability 
( ) ( )
1
// 22
1 −
−
=
+++ ∑∑
P
nnnn
C
ij
ij
iij
ij     (eq. 4.5) 
 
( )
1
/2
2 −
−
=
+++++ ∑
P
nnn
C
i
i       (eq. 4.6) 
 
( )
1
/2
3 −
−
=
+++ ∑∑
P
nnn
C
iij
ji      (eq. 4.7) 
 
 
To calculate the variance due to each category, set the MS= E<MS>, leaving 3 equations with 3 
unknowns: 
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2
Σσ = MS(MEAS. ERROR)     (eq. 4.8) 
 
 
3
2
2 )(
C
LOCATIONMS
L
Σ−= σσ     (eq. 4.9) 
 
2
2
1
2
2 )(
C
CPATIENTSMS L
P
σσσ −−= Σ     (eq. 4.10) 
 
 
 
For the final analysis, calculate the percentage variance for each category: 
 
total variance:      (eq. 4.11) 2222 PLT σσσσ ++= Σ
 
% total variance for patient variability = 2
2
T
P
σ
σ    (eq. 4.12) 
 
% total variance for location variability = 2
2
T
L
σ
σ    (eq. 4.13) 
 
% total variance for measurement error = 2
2
Tσ
σΣ    (eq. 4.14) 
 
4.4  Results 
 The mean ± one standard deviation spectra for normal ectocervix (panel a) and 
endocervix (panel b) are shown in figure 4.1. The major peaks are labeled and are conserved 
between both categories. 
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Figure  4.1: Normal Ectocervix vs. Normal Endocervix.  
(a) mean spectra (solid) +/- 1 standard deviation (dotted) is shown for all unique normal ectocervix (squamous 
epithelium) (n=100 spectra, 36 patients) (b) mean spectra (solid) =/- 1 standard deviation (dotted) is shown for all 
normal endocervix (columnar epithelium) (n=8 spectra, 7 patients). 
 
 
A comparison of the two mean spectra reveals that the peak intensities at 1006, 1055, 1083, 1550 
and 1657 cm-1 are similar.  Differences emerge at 1272 cm-1 and 1324 cm-1 where the intensities 
are higher in the endocervix spectra and at 1450 cm-1 where the intensity in the endocervix 
spectra is decreased. The standard deviation remains fairly constant across the wavenumber axis 
and varies between 0.18-0.40. It should be noted that only one spectrum per individual location 
was used in this analysis, such that if three measurements were made at each location, only one 
of those spectra were used. 
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Figure  4.2: Signal to Noise Calculations for Different Measurement Times.   
Signal to noise was calculated for 15 spectra from 5 patients collected using different measurement times. Signal 
was estimated using the Intensity of the 1450 cm-1 peak. Noise was estimated using the region surrounding 1700 
cm-1. 
 
 
 Figure 4.2 shows the results from the analysis to determine the optimal signal collection 
time in a bar chart comparing the average signal to noise ratio for each integration time.  The 
signal to noise ratio increases linearly with the measurement time until 5 seconds. Conversely, 
the increase in signal to noise at 8 seconds and 15 seconds is not proportional to the increase in 
signal collection time. Since the signal to noise ratio for 5 seconds was similar to that of the 
longer integration times, 5 seconds was chosen for the measurement time in subsequent studies. 
  A comparison of the mean spectra measured before and after the application of acetic 
acid is shown in figure 4.3a with the corresponding results of the t-test at each wavenumber in 
figure 4.3b. 
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Figure  4.3: Acetic Acid Analysis. 
(a) mean spectra of high grade dysplasia before and after acetic acid. (b) corresponding t-test performed at each 
wavenumber (c)  average intensity difference between spectra measured at a given site before and after the 
application of acetic acid for the 10 major peaks at individual time points (the data are divided into dysplasia (n=3 
patients, 6 sites of measurement), normal ectocervix (n=4 patients, 12 sites of measurement), and squamous 
metaplasia (n=2 patients, 3 sites of measurements). 
 
 
The mean spectral overlay shows two areas of difference: the intensity at peaks 1006 and 1305 
cm-1. The t-test indicates that neither of these differences are significant (at the level of p<0.01), 
although the difference at 1305 cm-1 has a significance of p=0.016. A bar chart illustrating the 
spectral differences at different time points following the application of acetic acid is shown in 
figure 4.3c. The bar chart is stratified according to pathology type.  Although there are outlier 
points in the 31-60 and 121-180 second groups, the spectral differences remain fairly constant 
across all time points, and the average magnitude of the spectral difference (0.15) is only slightly 
higher that seen in repeat measurements of the same site with no change in acetic acid 
application (0.12 – see figure 4.4). 
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Figure  4.4: Intrasite variation. 
The mean difference (or error) between the initial spectrum collected at a site and subsequent spectra measured 
either with the probe kept in place or removed and replaced to the same site is shown. The error bars represent one 
standard deviation. 
 
 
 Figures 4.4 and 4.5 show the results from the components of variance analysis in which 
the variation from between patients, between sites in a single patient, and within a site are 
quantified.  Intrasite variation is illustrated in figure 4.4.  Although the average spectral error is 
slightly higher when the probe was removed and replaced, the difference is not significant. The 
total variance at each wavenumber is plotted in figure 4.5a. 
 
 
 
66
010
20
30
40
50
60
70
80
patient location intrinsic
measurement
source of variance
%
 to
ta
l v
ar
ia
nc
e
a
b
%
 to
ta
l v
ar
ia
nc
e
 
Figure  4.5: Components of variance.  
A total of 180 spectra of normal ectocervix from 29 patients were used for this analysis. (a)  total variance at each 
wavenumber, (b)  percent of total variance due to interpatient (between patients), intrapatient (between locations), 
and intrinsic measurement variability. 
 
 
Although the variance curve does not approximate the spectral curve (figure 4.1), the spikes in 
variance occur mainly at the sites of major spectral peaks.  Figure 4.5b shows the relative 
contribution of variance from different sources as calculated by Henderson's method [18].  The 
largest source of total variance is due to interpatient variability.  The intrapatient, or variability 
due to different locations within a patient, is neglible (7%) and contributes less to the overall 
variability than the error intrinsic to the measurement process (20%). 
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Figure  4.6: Comparison of Spectra from Premenopausal and Postmenopausal Patients. 
(a) overlay of mean spectra of normal ectocervix from premenopausal (47 spectra from 17 patients) and 
postmenopausal (n=43 spectra from 18 patients) (b) results from t-test performed at each wavenumber. 
 
 
 Figures 4.6-4.8 examine three potential sources of interpatient variability.  In figure 4.6, 
the spectra from normal ectocervix are stratified according to menopausal status, and the mean 
spectra from pre-menopausal and post-menopausal women are compared.  The peak at 1324 cm-
1, the shoulders at 1100 and 1405 cm-1, and the region around 1600 cm-1 are all areas of visual 
spectral distinction (figure 4.6a) and statistically significant differences (figure 4.6b). 
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Figure  4.7: Comparison of Normal Ectocervix Spectra from Normal Patients and Dysplasia Patients. 
(a) mean spectra from normal ectocervix from the normal study (n=22 spectra from 11 patients)  and dysplasia study 
(n=25 spectra from 15 patients) (note: only spectra from pre-menopausal patients were used). (b) results from t-test 
performed at each wavenumber. 
 
 
 The mean normal ectocervix spectrum from pre-menopausal patients with normal 
cervices is compared with that from those with cervical dysplasia in figure 4.7. The analysis was 
limited to pre-menopausal patients as to not confuse actual spectral differences with those due to 
menopausal status. Although, histologically, the normal ectocervix from normal and dysplasia 
patients appear identical, there are spectroscopic differences between the two different sources of 
normal.  The most notable visual distinctions appear in the peaks at 1006, 1055, 1244 and 1450 
cm-1.  A closer look at the plot of the significance levels in figure 8b shows that there are several 
regions of statistically significant differences in addition to the ones indicated above. 
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Figure  4.8: Comparison of Spectra from Smokers and Non-smokers. 
(a) overlay of mean spectra of normal ectocervix from normal smoking (n=10 spectra from 5 patients) and 
nonsmoker (n=33 spectra from 11 patients) (b) results from t-test performed at each wavenumber. 
 
 
 A spectral comparison of normal ectocervix spectra from smokers is compared with non-
smokers in figure 4.8.  The only visual differences in major peaks between the mean spectra are 
seen at the 1450 and 1655 cm-1 peak, neither of which is significant at p<0.01.  The only 
significant difference is seen at the shoulder ~1030 cm-1.  
 
4.5  Discussion 
 Raman spectroscopy has the potential to provide real time, non-invasive diagnosis, yet 
non-trivial amount of spectral variation exists between different spectral measurements of the 
same tissue pathology. In an attempt to better understand the origins and relative contributions of 
the sources of this variation, this study analyzed and quantified the different sources of variance 
within spectra of normal ectocervix.   
 Analysis of the signal to noise ratio of spectra collected using different integration times 
indicated that 5 seconds would be the optimal measurement time for this and future studies in the 
cervix using the current Raman spectroscopy system. The signal to noise ratio for spectra 
collected using a 5 second signal collection time is comparable to the signal to noise ratio for 8 
or 15 second measurements (figure 4.2) and has the advantage of minimizing any probe 
movement during the signal collection that could lead to an increase in measurement error. 
Although the signal to noise ratio might be slightly higher with the 8 or 15 second signal 
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collection time, user error becomes more of a concern as the inability to hold the fiber optic 
probe steady for that length of time increases the likelihood of variability due to extraneous 
movement of the probe on the surface of the tissue. 
 The acetic acid analysis identified 2 areas within the spectra that show a visual spectra 
difference before and after the application of acetic acid (figure 4.3).  Although these differences 
are not significant, they do give insight into the changes that occur after the application of acetic 
acid.  These two peaks do show statistical differences between normal ectocervix and high grade 
dysplasia as well as normal ectocervix and squamous metaplasia (see chapter 3). The application 
of acetic acid enhances these changes, and thus it would seem advantageous to apply the acetic 
acid for the detection of dysplasia, both for the visual and spectral distinctions which are 
enhanced when it is applies. These results are comparable to an analogous study of the effect of 
acetic acid in fluorescence spectroscopy of the cervix [14]. Figure 4.3c indicates that there are no 
time dependent changes as a result of the acetic acid, so although acetic acid should be applied 
prior to spectral measurement for optimal results, it does not seem necessary to standardize the 
time after the application for taking spectral measurements. 
  The analysis of the components of variance revealed that the main source of variance 
between spectra of normal ectocervix lies in patient to patient variation (figure 4.4).  Although 
this finding was expected, the corresponding finding that intrapatient variation (or the variance 
from one location of normal ectocervix to another in the same patient) is responsible for only 7% 
of the total variance, less than the intrinsic measurement error, was not expected.  This finding 
indicates that there is little variation in normal tissue biology within a given patient, and thus 
there is no need to make multiple measurements of normal in a given patient, as the spectra 
should not be significantly different between different locations. This finding is corroborated by 
the results from figure 4.5.  Figure 4.5 shows that there is no significant difference between 
repeat measurements keeping the probe in place versus removing and replacing the probe.  This 
indicates that even if the probe is replaced in a slightly different location than the original 
placement, the spectra will not vary.  This is likely due to the fact that the tissue is homogenous, 
and thus the slight change in location does not affect the spectra. However, this finding cannot be 
extrapolated to measurements of dysplastic areas.  Since dysplastic lesions are by nature 
heterogeneous, one area of dysplasia may not have the same spectral characteristics as the 
adjacent area.  Thus, probe placement becomes a larger source of variability for measurements of 
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dysplasia, and multiple measurements would be necessary to ensure an adequate representation 
of disease status. The spectral variation due to intrinsic measurement error accounts for less than 
2% of the overall signal intensity.  Several potential sources for this error are possible including 
motion artifact, throughput variations, and variation due to intrinsic to the interaction of tissue  
biology and Raman spectroscopy. 
 Since interpatient variation is the largest source of total variance, it is likely that 
demographic differences contribute to the overall observed spectral variation. Menopausal status 
has been shown to a large source of spectral variance in studies of cervical dysplasia using 
fluorescence spectroscopy [19].  The spectral differences seen between pre-menopausal and post-
menopausal patients in figure 4.6 are likely a major source of the quantified interpatient variance. 
Most notably, there is a significant difference in the intensity at 1324 cm-1.  Since this peak has 
also been shown in a concurrent study to be one of the key spectral differences in distinguishing 
cervical dysplasia from normal ectocervix, it is likely that future studies will need to stratify the 
data according to menopausal status and develop separate classification algorithms specific to 
menopausal status (chapter 3). Due to the patient population (many patients had continuous 
menstrual bleeding or spotting due to uterine malignancy) and lack of sufficient numbers of pre-
menopausal patients, we were unable to stratify the data according to cycle status in this analysis. 
Yet, future studies should carefully control or stratify data according to menstrual cycle status to 
fully understand the contribution of hormonal status to spectral variation.   
  One of the unexpected findings of the study was the significant differences seen between 
spectra of normal ectocervix measured from patients with normal cervices as compared with 
spectra of normal ectocervix measured from patients with cervical dysplasia (figure 4.7). This 
finding indicates that Raman spectroscopy may be able to detect differences in tissue biology 
which are not evident during histological examination.  It also raises the question of whether 
Raman spectroscopy is detecting changes that are occurring at the subcellular level in normal 
tissue in the context of dysplasia. Such changes, termed malignancy associated changes, have 
been documented using high resolution image analysis of cervical smear specimens [20]. In the 
aforementioned study, the observed malignancy associated changes increased in intensity with 
the increase in grade of dysplasia. Whether or not the spectral changes observed actually reflect 
the presence of malignancy associated changes remains unknown and should be the subject of 
future research.    
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 Overall, the analysis of variance presented in this paper aids in the understanding of the 
sources of the variation in the Raman spectra of tissue and how this variation affects the ability 
of Raman spectroscopy to discriminate between different pathologies. Since the majority of the 
spectral variance from a single pathology emanates from patient to patient variability and not 
from variability within a given patient, clinical studies can be more efficiently designed to 
eliminate unnecessary repeat measurements.  Similarly, since menopausal status contributes 
significantly to the interpatient variance, clinical trials and data analysis can now be modified 
according to menopausal status; this should improve the accuracy of discrimination algorithms 
that distinguish between normal and dysplasia spectra.   Results from the acetic acid analysis 
indicate that the application of acetic acid enhances some of the spectral changes between normal 
and dysplasia spectra, and thus it would be advisable to always apply acetic acid before spectral 
measurement, though regulation of the time after application is not critical. Other differences 
such as those between normal spectra taken from patients with normal cervices and those with 
dysplasia will require more research to fully understand how this will affect the ability of Raman 
spectroscopy to perform diagnosis. 
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5.1  Abstract 
 There is a growing body of evidence showing that optical spectroscopy has the potential 
to be a useful in vivo diagnostic tool. Yet, so far there is no definitive cellular and biochemical 
understanding for the differences seen in the spectra from different tissue categories and disease 
states. In this study, we examine the use of organotypic raft cultures as an in vitro model of in 
vivo tissue conditions in an attempt to overcome some of the limitations of previously used 
methods. Organotypic raft cultures resembling normal and dysplastic epithelial cervical tissue 
were constructed and grown at an air–liquid interface for 2 weeks. Raman spectra of normal as 
well as dysplastic raft cultures were measured and compared with in vivo spectra from the 
corresponding tissue type. Histologic comparisons ensured that the raft cultures had similar 
structure and morphology to the corresponding intact tissue types. Raman spectra were also 
acquired from different layers of tissue. Spectral comparisons show that the Raman spectra of the 
raft cultures are similar to the spectra acquired from the cervix in vivo for both normal and 
dysplastic tissues. These results show that organotypic raft cultures are an effective and useful 
tool for the cellular and biochemical analysis of tissue spectroscopy. 
 
5.2  Introduction 
 Optical spectroscopic methods are increasingly being applied to detect tissue pathology 
due to their ability to provide real-time, non-intrusive, and automated information. Numerous in 
vitro and in vivo studies have documented the potential of fluorescence, diffuse reflectance, near-
infrared absorption, and Raman spectroscopy to perform automated tissue diagnosis alone or in 
combination [1]. Among these, Raman spectroscopy is particularly well suited to probe the 
biochemical changes seen with carcinogenesis since Raman spectroscopy examines many 
specific chemical bonds present in tissue rather than just a few and provides a highly specific 
spectral fingerprint. Raman spectroscopy thus far has shown to be a promising diagnostic tool for 
discrimination of precancerous and cancerous lesions in in vitro studies of the gastrointestinal 
tract [2], larynx [3], breast [4], skin [5], cervix [6] and in vivo studies of cervix [7], esophagus 
[8], colon[9], skin [10], and rat carcinogenesis models [11].  
 Although these initial studies indicate that optical spectroscopy has the potential to be a 
useful in vivo diagnostic tool, there is limited understanding of how the variability of different 
tissue components and conditions affects the spectra of tissue. Detailed knowledge of the 
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morphologic and biochemical basis of the observed spectral features has several foreseeable 
benefits. First, an understanding of the interactions of tissue biology with spectral changes could 
influence the design of the fiber optic probe used to deliver and collect the light from the tissue 
[12]. For example, if such studies were to indicate that diagnostically significant spectral 
information emanates from a particular tissue region, a fiber optic probe could be designed to 
maximally collect light only from that region. Second, such a fundamental understanding could 
lead to more informed in vitro and in vivo clinical study design. Third, for optical spectroscopy 
to be useful clinically, automated diagnostic algorithms capable of distinguishing spectra from 
various normal and non-normal tissue categories must be designed and implemented. Thus far, 
unbiased statistical algorithms using methods such as linear discrimination based on Bayes’ 
theorem [6] and artificial neural networks [13] have been used to design these algorithms.  
Although such statistical methods could prove to be sufficient for automated diagnosis once 
large data sets are collected, rational design of diagnostic algorithms requires an understanding 
of the biochemical and tissue morphology changes that underlie the spectral changes. This 
understanding could in turn prove to be critical in the development of more robust algorithms.  
   In recent years, the primary tool used to investigate the molecular basis for tissue spectra 
has been frozen tissue microspectroscopy. Several tissue microspectroscopy studies have 
elucidated the spectral features of various tissue components such as collagen, fat, and epithelial 
cells and the contributions of these components to tissue spectra using mathematical models [10, 
14, 15]. Yet, none of these methods are capable of determining the basis of the variation in the 
spectral signal due to intrinsic tissue components, in unknown quantities in tissue, nor have they 
proven to be very useful in determining how these components affect the ability for spectroscopy 
to perform diagnosis. In this study, we examined the use of organotypic raft cultures as a 
controlled in vitro model of in vivo tissue conditions in an attempt to understand how alterations 
in tissue biology affect tissue spectroscopy.  
 Organotypic cultures are multilayer, three dimensional cultures designed to reproduce the 
in vivo structure and function of tissue. Organotypic cultures are typically used as a model 
system when differentiation of cells and cell-cell interaction within a tissue structure is critical to 
the understanding of the underlying process [16]. Raft cultures represent a specific type of 
organotypic cultures that reconstruct epithelial tissue types that consist of an avascular 
epithelium that attaches via a basement membrane to a supporting connective tissue stroma.  Raft 
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cultures have enabled investigation of problems involving cell-cell interactions [17], epidermis-
dermis interactions [18], gene therapy [19, 20], viral pathogenesis [21],  immunologic regulation 
[22], and transformation of normal epithelium to dysplastic epithelium [23]. 
 Although organotypic cultures have been used for many years as a model system in many 
different fields of study, only recently have organotypic cultures been proposed as a model 
system for tissue spectroscopy [24].  To our knowledge, no studies to date have demonstrated the 
utility of organotypic raft cultures for analysis of spectroscopic data. We propose that 
organotypic cultures are a useful model system that could provide insight into the ability and 
limitations of spectroscopy to provide automated diagnosis; the ability to control and manipulate 
tissue components and culture conditions will enable experiments that yield information 
complementary to frozen tissue microspectroscopy studies.  By mimicking an in vivo 
environment, the spectroscopic features of tissue components can be examined in their natural 
environment. Concentrations and types of tissue components can be manipulated, and the 
resulting spectra can be analyzed to determine the spectral contributions of individual tissue 
components. 
 Thus, this study aims to assess the potential of organotypic raft cultures as a novel model 
system for understanding the biochemical and cellular basis for spectral features and thus the 
diagnostic potential of tissue Raman spectroscopy. The goal of this paper is to present a robust 
method for a model system that is useful in tissue spectroscopic analysis.  To accomplish this 
aim, the ability of organotypic raft cultures to accurately model human cervical tissue for Raman 
spectroscopic analysis was tested. Raft cultures were constructed to resemble normal and 
dysplastic human cervix. The raft cultures were compared both morphologically (via histology) 
and spectroscopically (via Raman spectroscopy) to in vivo tissue data from an ongoing clinical 
study using Raman spectroscopy for the detection of cervical precancers [25]. Two different 
types of squamous cell carcinoma cell lines (see table 1) were used to generate the dysplastic 
cultures, thus allowing investigation into the spectral variation associated with varying epithelial 
cells. Additionally, the epithelium was separated from the stromal layer in the raft cultures such 
that the Raman spectra could be measured from the individual layers to understand the 
contributions of the two main layers of cervix. These results were then compared to Raman 
spectra measured from the epithelial and stromal layers separated from intact normal cervical 
tissue samples in vitro. Additional studies examined the effect of the epithelial thickness on the 
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overall Raman spectra. Thus, the utility of raft cultures as a suitable model system for the 
preliminary understanding of the effect of tissue morphology and biochemistry on optical 
signatures was demonstrated. 
   
5.3  Materials And Methods 
 
5.1.1  Construction of Rafts 
 Four different cell lines were used in the construction of the organotypic raft cultures. 
Normal human neonatal dermal fibroblasts (NHDF, Cambrex Co., East Rutherford, NJ) were 
used in the formation of the stromal layer for all raft cultures. The epithelial component was 
formed using one of three different cells lines, either Normal Human Neonatal Foreskin 
Keratinocytes (NHK, Cambrex Co., East Rutherford, NJ), Epidermoid Carcinoma from skin (A-
431, ATCC, Manassas, VA), or Squamous Cell Carcinoma cells from the cervix (SiHa, ATCC, 
Manassas, VA) depending on the type of tissue and disease state (normal vs. dysplasia) desired 
for study.  Table 1 diagrams the cell lines and the corresponding growth media used. 
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Figure  5.1: Construction of an organotypic culture 
(a) Thick layer of collagen, (b) Fibroblast cells mixed with collagen matrix, (c) Epithelial cells seeded on top of 
matrix with culture media (d) Fibroblasts cause contraction of collagen matrix and (e) Differentiation of epithelial 
cells after 10-15 days growth at air-liquid interface [17]. 
 
 
 Figure 5.1 illustrates the steps taken in the formation of the organotypic raft cultures. The 
stromal equivalent is formed first by mixing 1 part reconstitution buffer (2.2% NaHCO3, 0.05 M 
NaOH, 200mM HEPES buffer), 2 parts five-fold concentration High Glucose DMEM (Sigma, 
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St. Louis, MO), 6.5 parts collagen solution (3.5-4.3 mg/ml rat tail collagen type I in 0.02 N acetic 
acid from BD Biosciences, Bedford, MA).  NaOH (1 N) was then added to the solution until a 
neutral pH was obtained (indicated by phenol red). To this solution, 0.5 part of cell solution 
containing NHDF cells suspended in the growth medium (DMEM +10% FBS) at a concentration 
of 8 X 106 cells/ml is added. Two milliliters of this collagen-fibroblast solution is then poured 
into individual wells of a 24 well plate (Costar, Corning, NY) and allowed to solidify overnight 
in an atmosphere of 37°C, 5% CO2. For example, to make the stromal layers for four rafts, 1 ml 
reconstitution buffer, 2ml 5X DMEM, 6.5 ml of collagen solution, approximately 25 µl 1 N 
NaOH, and 0.5 ml DMEM containing 4 X 106 NHDF cells are mixed and poured into 4 wells. 
Note: the addition of collagen to the solution causes a contraction of the total volume such that 
even though 10 ml of total solution is added, the final volume is only 8 ml. 
 Following the formation of the stromal equivalent, one of three types of epithelial cells (3 
X 105 cells suspended in 1ml of Keratinocyte Growth Media (KGM-2, Cambrex Co., East 
Rutherford, NJ) is added to the top of each raft. The epithelial cells are allowed to attach during 
an overnight incubation, and the following day, the rafts are gently separated from the side walls 
of the well plate using a sterile spatula.  This allows the rafts to contract and form a more dense, 
tissue-like consistency.  After overnight incubation, the rafts are placed onto a 25 mm wire mesh 
(Sigma, St. Louis, MO) with the epithelial cells facing up.  Raft Media (see table 5.1) is then 
added such that the media reaches the level of the wire mesh but no part of the raft is submerged.  
The raft cultures are incubated for 10-12 days in an atmosphere of 37°C, 5% CO2 with a change 
of media every other day. 
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 Table 5.1: Cell lines used in construction of raft cultures 
Cell Line Cell Line Description Growth Media 
NHDF (Clonetics) Normal Human Neonatal 
Dermal Fibroblast 
High Glucose Dulbecco’s 
Modified Eagle’s Medium 
(DMEM, Sigma) + 10% 
Fetal Bovine Serum (FBS, 
Clonetics) 
NHK (Clonetics) Normal Human Neonatal 
Dermal  Keratinocyte 
Keratinocyte Serum Free 
Media (Invitrogen) 
A-431 (ATCC) Human Epidermoid 
(Squamous Cell) Carcinoma 
High Glucose DMEM +10% 
FBS 
SiHa (ATCC) Human Cervical Squamous 
Cell Carcinoma 
Modified Eagle’s Media 
(MEM, Sigma) + 10% FBS 
Raft Cultures   Raft Media (1 part 
Keratinocyte Growth Media-
2 (Clonetics) 
1 part High Glucose DMEM 
+10% FBS) 
 
 
 Raft cultures grown from 6 different experiments were used for the analysis presented 
here. An experiment is defined as the formation of a set of raft cultures following the same 
protocol but utilizing unique flasks of cells, new batches of collagen solution, and begun on 
different days. In each experiment, an average of 3 distinct rafts of each epithelial cell type 
(A431: Epidermoid Carcinoma cells, SiHa: Squamous Cell Cervical Carcinoma, NHK: Normal 
Human Neonatal Dermal Keratinocytes), were grown resulting in an average of 9 raft cultures in 
each experiment.  Raman spectra were acquired from each raft. Spectra from the rafts of each 
epithelial cell type were averaged from each experiment, thus each experiment was subsequently 
treated as n=1 for statistical analysis. 
 
5.1.2  Measurement of Raman Spectra 
 Raman spectra were collected from all raft cultures with a macroscopic Raman 
spectroscopy system (figure 2) utilizing a fiber optic probe for light delivery and collection.  
 
 
 
82
 CCD
NF
BP
Probe
Diode Laser
785 nm, 80 mW
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Computer  
Figure  5.2: Raman spectroscopic system used for data collection. 
Note: CCD: Charged Coupled Device, NF: notch filter at 785 nm, BP: band pass filter at 785 nm 
 
 
  The system consists of a 785 nm diode laser (Process Instruments, Inc.) set at 80 mW, 
fiber-optic probe (Visionex Inc.), a spectrograph (Kaiser Optical Systems, Inc), and a back-
illuminated, deep-depletion, liquid nitrogen cooled CCD camera (Roper Scientific Inc.) all 
controlled with a laptop computer.  The fiber-optic probe contains a single, central excitation 
fiber of 400 µm core diameter surrounded by seven 300 µm beam-steered collection fibers [26]. 
The collected light is then filtered with an inline notch filter at 785 nm within the probe itself to 
attenuate light at the laser wavelength. The light is then fed into the spectrograph where it is 
filtered again with a holographic notch filter at 785 nm and dispersed onto the CCD camera 
where the computer records the signal. 
 During spectral measurements from the raft cultures, the rafts remained on the metal grid 
but were removed from the petri-dish containing the media. The fiber-optic probe was placed in 
light contact with the raft, and Raman spectrum was recorded using an integration time of 15 
seconds.  Raman spectra were measured from two different sites on each raft and averaged for 
final analysis. The probe was rinsed with sterile normal saline between measurements of each 
raft. After spectral acquisition, one raft from each epithelial cell type was fixed in 10% formalin, 
sectioned, and stained with hematoxylin & eosin (H & E) for histologic examination. The 
histology of the raft cultures was compared with typical histological sections of corresponding 
tissue type and disease category. Raman spectra from the raft cultures were compared to Raman 
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spectra acquired in vivo from the cervix of human patients undergoing excisional procedures as 
part of an ongoing pre-clinical study assessing the potential of Raman spectroscopy for cervical 
dysplasia detection [25]. 
 
5.1.3  Epithelium and Stroma Measurements: Raft Cultures 
 After Raman spectra were collected from each intact raft, the epithelial layer was 
removed from the underlying stroma using either forceps (NHK rafts) or a scapel (A-431 and 
SiHa rafts) from the remaining two rafts from each epithelial cell type (not including the raft sent 
for histology). The thin layer of epithelium was placed on the metal grid alongside the remaining 
stromal layer.  Raman spectra of the epithelial and stromal layers were collected separately using 
the same system (figure 5.2) and protocol used to collect spectra from the intact raft cultures.   
 
5.1.4  Epithelium and Stroma Measurements: Tissue 
 To further validate raft cultures as a suitable model system, Raman spectra from the 
epithelial and stromal layers of the raft cultures were compared with spectra from separated 
epithelial and stromal layers of cervical tissues. Tissue samples of the normal ectocervix were 
obtained from hysterectomy specimens as approved by the Vanderbilt IRB. The samples were 
kept frozen at -80°C until analysis. Unlike in the raft cultures where there is no basement 
membrane attaching the epithelial layer to the stromal layer, the basement membrane present in 
the tissue necessitates a chemical separation process to break the bonds connecting the 
epithelium and stromal layers. Thermolysin, a zinc endopeptidase, cleaves bonds found in the 
lamina lucida (one component of the basement membrane), thereby separating the epithelium 
from the connective tissue at the level of basement membrane [17].  
 Tissue specimens were thawed in PBS (phosphate buffered saline) at room temperature at 
the time of study. Raman spectra were measured from each intact specimen. The ectocervix 
specimens were then submerged in a 750 µg/ml solution of thermolysin in 10 mM HEPES, 1mM 
CaCl2, pH 7.2 and incubated at 37°C for 2-3 hours [17]. After incubation, a thin film of 
epithelium was removed from the top of the tissue specimen and placed on a sheet of aluminum 
foil or on the metal grids used for the raft cultures alongside the remaining stromal layer. Raman 
spectra were measured separately from the thin sheet of epithelium and the remaining stroma.  
All Raman measurements were taken with the previously described system (figure 5.2) and 
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protocol. Raman spectra acquired from the epithelia and stroma of intact tissues were compared 
to the corresponding spectra from raft cultures. Additionally the spectra were also compared to 
the intact tissue and raft culture spectra to assess the effect of each layer on the integrated tissue 
signature.  
 
5.1.5  Thickness Analysis 
 To determine the effect of epithelial thickness on the overall Raman spectra, raft cultures 
were constructed using NHK and SiHa epithelial cells as described above. Five experiments 
were conducted; in each experiment, three raft cultures of each epithelial cell type were grown.  
Raman spectra were collected from the raft cultures on days 4, 8 and 14 after the raft cultures 
were raised to an air-liquid interface. On each day of spectral measurement, one raft culture per 
epithelial cell type was fixed in 10% formalin, sectioned, and stained with hematoxylin & eosin 
(H & E) for histologic examination following the collection of Raman spectra. 
 
5.1.6  Data Pre-Processing and Extraction 
 Prior to each experiment, a spectral calibration of the system was performed using a 
neon-argon lamp and napthalene standard to correct for system wavenumber, laser excitation, 
and throughput variations. For each Raman spectrum measured, the signal from the CCD camera 
was binned along the vertical (intensity) axis to create a single spectrum per measurement site. 
Only signal between 950 – 1850 cm-1 was considered for further analyses due to the interference 
of silica bands below 950 cm-1 from the fiber optics probe. The spectrum was then binned along 
the horizontal (wavenumber) axis such that each data point represents the intensity from 3.5 cm-
1. The spectrum was then filtered using a 2nd order Savitzky-Golay filter (window =17.5 cm-1) for 
noise smoothing [27]. Fluorescence subtraction was accomplished using a modified polynomial 
fitting method in which a 5th order polynomial is fit to the fluorescence baseline. Following data 
processing, each spectrum was normalized to its mean spectral intensity across all Raman bands 
to account for overall intensity variability. These normalized spectra were used for further 
comparison and analysis. 
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5.4  Results 
 Histopathological examination on a representative raft from each of the epithelial cell 
types in each experiment confirmed the pathology. Rafts from all experiments showed consistent 
histopathologic patterns. H&E stained sections from representative raft cultures were compared 
to that from tissue biopsies of the corresponding pathologic category. Figures 5.3a, b compare 
histologic sections from an area of normal cervix to the histology from the raft culture made with 
NHK cells. The raft culture shows all stages of differentiation seen in the normal cervix 
including an undifferentiated basal layer overlying the stroma, a parabasal layer of cells above 
the basal layer, an intermediate layer above the parabasal layer, and the terminally differentiated 
top layer known as the superficial layer.  The layer of keratin seen above the normal raft culture 
arises due to the fact that dermal keratinocytes were used in these cultures in lieu of normal 
cervical keratinocytes. This layer is not present in the corresponding normal cervix. Figures 5.3e 
& f compare a histologic section from an area of high grade dysplasia with a raft culture 
constructed with SiHa cells.  The SiHa raft epithelium shows many of the same morphological 
characteristics seen in high grade cervical dysplasia.  For example, there is no differentiation or 
stratification of the epithelium; instead, cells appear undifferentiated throughout the epithelium 
and show a lack of organization within the epithelium, with significant nuclear atypia. The main 
differences between the raft section and the corresponding biopsy are seen primarily in the 
stromal layer.  The stromal layer from intact tissue contains connective fibers (such as collagen, 
elastin) as well as fibroblasts, inflammatory cells and capillaries. Since the raft cultures were 
constructed only with collagen, concentrated media, and fibroblasts, the cultures lack the 
inflammatory cells and capillaries. Thus the stromal layer of the raft section appears less 
crowded than the stromal layer of the tissue. 
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Figure  5.3: In Vivo Raft Culture Histology and Spectral Comparison. 
Histology of (a) normal squamous epithelium of the cervix and (b) a normal raft culture using human keratinocytes 
(NHK). Note: the arrow represents the direction of keratinocyte differentiation; beginning in the basal layer as 
undifferentiated cells (U) and moving upwards to become fully differentiated cells (D).  Average Raman spectra of 
(c) normal cervical tissue using 49 measurements from 24 patients in vivo and (d) 18 normal rafts from 6 different 
experiments. Histology of (e) high grade dysplasia of the cervix and (f) a dysplastic raft culture using cervical 
squamous cell carcinoma cells (SiHa). Average Raman spectra of (g) dysplastic lesions acquired in vivo using 12 
measurements from 6 patients and (h) 18 SiHa rafts from 6 different experiments. 
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These morphological similarities and differences in the histology of the raft cultures described 
above are consistent with previous reports of raft cultures constructed with normal and cancerous 
cell lines [23]. The mean Raman spectra from the normal raft culture and normal in vivo cervix 
are shown in figures 5.3c & d.  Direct comparison of the spectra shows similarities in the shape 
of the Raman bands and their relative intensities with some variability in the specific intensities 
of these bands. The corresponding mean Raman spectra from the SiHa raft and in vivo tissue 
dysplasia lesion show similar trends (figures 5.3g &h). 
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Figure  5.4. Mean and standard deviation spectra for raft cultures.  
The mean (solid line) ± one standard deviation (dotted lines) of the Raman spectra from (a) normal (NHK cells) 
rafts, (b) dysplastic (SiHa cells) rafts and (c) dysplatic (A431 cells) rafts (n=6 experiments, 18 raft cultures in each 
category). 
 
 
 The Raman spectra of all the raft cultures from six different experiments were averaged 
by epithelial cell type. The mean ( ± one standard deviation) Raman spectra from 18 rafts from 
these six experiments are plotted for each of the three different epithelial types in figure 5.4. All 
spectra have been normalized to the mean spectral intensity for comparison. To quantify the 
amount of variation between different experiments, the standard deviation was calculated at each 
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point along the normalized spectrum.  The mean of these standard deviation values (across the 
spectrum) was then calculated to determine a mean normalized standard deviation for each group 
of raft cultures. The spectra from raft cultures were observed to be very consistent across the 
entire fingerprint region for all experiments with a mean normalized standard deviation equaling 
0.1326  (A431), 0.15071 (NHK), 0.14654 (SiHa).  
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Figure  5.5: In Vivo and Raft Culture Dysplastic/Normal Spectral Comparisons. 
Raman spectra from (a) normal and dysplastic areas of the cervix acquired in vivo [25] and (b) normal (NHK) and 
two types of dysplastic (SiHa, A431) raft cultures. (c) Difference spectra calculated between normal and dysplastic 
signals from raft cultures and in vivo tissues. The dotted box represents the major spectral differences observed. 
 
 
 Figure 5.5 compares the Raman spectra from normal and dysplastic samples of (a) intact 
tissue in vivo to (b) raft cultures.  The spectral differences seen between the SiHa (dysplastic) 
cultures and NHK (normal) cultures parallel those seen between high grade dysplasia and normal 
ectocervix in vivo. The box enclosing the 1270 cm-1 and 1325 cm-1 peaks represents the area of 
greatest visual spectral distinction between normal and dysplastic tissues. The shoulder at 1325 
cm-1 is noticeably higher in the dysplasia spectra (both raft culture and in vivo) when compared 
with the normal spectra, relative to the peak at 1270 cm-1, which remains constant.  To quantify 
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these spectral differences, ratios of peak intensities were calculated for all major peaks present in 
the Raman spectra (peaks used: 1058, 1086, 1270, 1325, 1454, 1655 cm-1) with respect to each 
other.  An unpaired Student’s t-test was then performed to compare the peak ratios between 
normal and dysplastic samples. A subset of the ratios compared and their corresponding p-values 
using spectra from raft cultures as well as in vivo samples [25] is presented side-by-side in table 
5.2.  
 
 
Table 5.2: Comparison of peak ratios between normal and dysplastic spectra acquired from raft cultures and 
in vivo tissue.  
The corresponding p-values are shown from t-tests comparing normal and dysplastic spectra from an ongoing 
clinical study, A431 and NHK raft cultures, and SiHa and NHK raft cultures, respectively. Statistically significant 
differences are shown in bold. 
In vivo Raft Culture 
Peak Ratio  
(cm-1) 
Normal vs. 
Dysplasia 
A431 vs. 
NHK  
SiHa vs. 
NHK  
1086/1270  0.307 0.774 0.278 
1086/1325 0.007 0.013 .00004 
1086/1454 0.451 0.00002 0.001 
1086/1655 0.957 0.043 0.046 
1270/1325 0.014 0.003 .00004 
1270/1454 0.110 0.017 0.241 
1270/1655 0.563 0.175 0.592 
1325/1454 0.024 0.556 0.005 
1325/1655 0.103 0.341 0.002 
1454/1655 0.299 0.258 0.391 
 
 
 As anticipated from figure 5, multiple peak ratios involving the band at 1325 cm-1 show 
statistically significant differences between normal and dysplasia tissues. Most notably, peak 
ratios at 1086/1325 and 1275/1325 cm-1 that show significant differences in vivo are observed to 
be significant in raft cultures as well. Only one peak ratio (1086/1454 cm-1) is inconsistent 
between in vivo data and both sets of raft culture data. A comparison of the difference spectra 
calculated between normal and dysplastic spectra from raft cultures and in vivo tissues highlight 
areas of the spectra where raft culture results deviate from that observed in vivo. While the 
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majority of the fingerprint region of the spectra shows good correlation, particularly between 
1250 cm-1 and 1400 cm-1, spectral differences are inconsistent around 1048, 1128, 1445 and 1660 
cm-1 between in vivo and raft culture spectra.   
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Figure  5.6: Raman spectra measured of epithelium and stroma 
Epithelium and stroma separated from (a) a normal cervical biopsy (b) normal raft cultures and (c) dysplastic raft 
cultures. 
 
 
 Figure 5.6 shows the results from the Raman spectral measurements of the two main 
layers of tissue, the epithelium and stroma. The mean spectra from the epithelia and stroma of 
raft cultures measured separately in six experiments are shown for NHK raft (figure 5.6b) and 
SiHa raft (figure 5.6c). (The Raman spectra from the epithelia and stroma of A431 raft cultures 
in initial experiments were similar to those of the SiHa rafts and thus  are not shown here).  In 
addition, Raman spectra were also measured from separated epithelia and stroma of five normal 
cervical tissue samples taken from hysterectomy specimens (results shown in figure 5.6a).  
Comparison of spectra acquired from intact cervical tissue layers with those from the raft 
cultures indicates that raft cultures show similar variations between the epithelial and stromal 
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spectra as the spectra measured from the layers of intact tissue.  Of note is the striking difference 
seen in the 1270 cm-1 and 1325 cm-1 peaks between the stromal and epithelial spectra. The 
stromal spectrum shows peaks at 1240 cm-1 and 1270 cm-1 similar to those seen in the in vivo 
data with relatively lower peak intensity at 1325 cm-1. The epithelial spectrum, in contrast, shows 
a strong peak at 1325 cm-1, and a much smaller peak at 1270 cm-1. In comparing the epithelial 
spectrum from the SiHa rafts (figure 5.6c) with those from intact normal tissue (figure 5.6a) and 
the NHK rafts (figure 6c), the SiHa epithelial spectrum appears to have an even greater increase 
in the 1325 cm-1 peak as well as an increase in the 1454 cm-1 peak, a change not observed in the 
intact normal and NHK raft epithelial spectra. 
 
 
 
92
a b c  
Figure 5.7: Ef
Histology from
raised to the ai
 
 
 The r
Raman spec
14 are shown
slowly incre
of epithelial 
Raman spec
1300-1321 c
peak at 1048
 
 
 50 µm 
fects of Epithelial Thickness on Rama
 SiHa (dysplastic) raft cultures is shown
r liquid interface (d) corresponding Ram
esults of the experiments looking
tra are shown in figure 5.7. Histol
 in progression in figure 5.7a, b, 
ases from 50 µm at 4 days to 125 
cells which appear to be invading
tra shown in figure 5.7d show a pr
m-1 and the peaks at 1450 and 165
 cm-1 while the peak at 1244 cm-150 µm 
d 
n spectra. 
 for (a) day 4, (b) day 8, (c) day 14 after 
an spectra measured from raft cultures on
 at the effect of epithelial thicknes
ogy results from the raft cultures o
and c, respectively. The thickness
µm at 8 days to 200 µm with an a
 the stromal layer at 14 days.  The
ogressive increase in intensity in 
7 cm-1 from day 4-14. A decrease
 remains constant. 
9350 µm 
 
the raft cultures are 
 days 4, 8, and 14. 
s on the overall 
n days 4,8, and 
 of the epithelium 
dditional 60 µm 
 corresponding 
the region from 
 is seen in the 
5.5  Discussion 
 This study indicates that organotypic raft cultures can be used as an accurate, 
reproducible model system for spectroscopic analysis of tissue. Comparisons of this data from 
the raft cultures with data collected from an ongoing in vivo clinical study [25] indicate that raft 
cultures are not only an accurate morphologic representation of in vivo tissue as shown by 
histology but also an accurate biochemical representation as shown by comparisons of Raman 
spectroscopy data. Histology results shown here are consistent with previous reports of raft 
cultures constructed using normal and cancerous epithelial cells [23]. Analysis of the Raman 
spectroscopy data shows that all of the major peaks present in spectra from in vivo data are also 
present in similar ratios in spectra from the raft cultures. This suggests that the raft cultures as 
described here truly represent the tissue biochemistry contributing to the overall Raman spectra 
(type I collagen, fibroblast cells, and epithelial cells).  Other minor components present in the 
raft culture arise from the media: epidermal growth factor (EGF), epinephrine, insulin, apo-
transferrin, hydrocortisone, penicillin/streptomycin/amphotericin B, pituitary hormones, 
inorganic salts, pyruvate, and amino acids. These minor components are unlikely to contribute to 
the overall Raman spectra due to their relatively low concentration when compared to the major 
components. However, future experiments using raft cultures will test this hypothesis and 
determine the significance of these minor constituents to tissue biochemistry and their affect on 
the Raman spectra.  
 As a model system for tissue spectral analysis, there are many foreseeable benefits to 
using organotypic cultures for analysis of tissue spectroscopy. Organotypic cultures may 
eliminate some problems associated with human tissue based studies such as difficulty acquiring 
tissue specimens and inherent diversity between tissue samples due genetics, patient 
demographics, and state of tissue. Although the ultimate goal is to develop optical spectroscopy 
to be robust enough to provide accurate diagnosis despite this inherent patient diversity, the 
ability to provide a reproducible model system will allow more accurate assessment of the ability 
of optical spectroscopy to distinguish a given pathology independent of patient variation. While 
the current study presents the benefits of these cultures in the context of Raman spectroscopy, 
such a model system can be used to understand and enhance other optical methods as well. In 
fact, organotypic cultures provide a system by which tissue variables can be controlled and 
manipulated, thus presenting an environment wherein the effect of certain variables (tissue 
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inflammation, individual biomolecular concentration, enzyme concentrations) on tissue optical 
spectra can be determined, unlike with actual tissue samples where variables such as molecular 
concentration are often unknown.  Additionally, since the cells within organotypic cultures are 
maintained viable, the cultures more closely simulate in vivo conditions as compared with in 
vitro tissue specimens where the cells begin to die once taken out of the body, thus altering the 
molecular composition of the tissue. 
 In a preliminary application of the raft culture system towards understanding the 
morphological and biochemical basis of cervical tissue Raman spectra, spectral differences 
between normal and dysplastic tissues grown in culture were compared to those observed in vivo. 
The raft as indicated by figure 5.5. Raman spectra of the raft cultures as well as in vivo human 
cervical tissues indicate that the region surrounding 1325 cm-1 shows the most consistent 
differences between normal and dysplastic tissues. However, inconsistencies between the raft 
culture and the in vivo data are evident at 1048, 1128, 1445, and 1660 cm-1. The discrepancy 
seen at 1048 cm-1 is likely due to differences in the contribution of silica Raman band in that 
region.  Since the raft cultures are placed on a metallic surface, there is an increased reflection of 
laser light back into the fiber optic probe. In addition, NHK rafts are typically thinner than SiHa 
rafts resulting in variability in the silica contribution from the two types of rafts.  Other 
variations in the Raman difference spectra around 1128, 1445, and 1660 cm-1 are attributed to 
differences in tissue biology between the rafts and intact tissue. Thus while the raft cultures 
appear to be an accurate and reproducible model system for cervical tissue, it may not yet 
include all the constituents of intact cervical tissue. Although the missing constituents have not 
yet been identified, future experiments will incorporate such changes as using tumor specific 
fibroblasts in the dysplastic rafts to identify the basis of the discrepancies at the afore-mentioned 
bands. Such planned studies will help uncover the origins of the spectral differences between 
normal and dysplastic cervical tissues leading to a better understanding of the morphologic and 
biochemical basis of tissue spectral signatures. 
 Figure 5.6 indicates that the differences seen in the 1325 cm-1 peak relative to the peaks at 
1240 and 1270 cm-1 may be associated with changes in the epithelial layer; the band at 1325 cm-1 
is predominant in the epithelial spectra whereas the stromal spectra is dominated by the peak at 
1270 cm-1 with virtually no feature at 1325 cm-1.  This is likely due to the high concentration of 
cells (and therefore nucleic acid) within the epithelial layer and is consistent with previous 
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studies in the skin (5). The 1325-1330 cm-1 peak has been attributed to a CH3CH2 wagging mode 
in the purine bases of nucleic acids [2].  Conversely, the 1270 cm-1 peak has traditionally been 
attributed to the Amide III a C-N stretch from alpha helix proteins [2], and thus is likely 
originating in the stromal region where the bulk of the proteins reside in the form of collagen. 
The band at 1655 cm-1 is primarily attributed to amide I vibrations and is typically associated 
with the collagen abundantly present in the stroma of cervical tissue [28]. However, the spectra 
acquired from the epithelial and stromal layers indicate that there may be another source for this 
peak within the epithelium, since there are few differences between the epithelial and stromal 
peaks at 1655 cm-1.  
 Thus, the changes seen in the relative magnitude of the 1325 cm-1 peak can be primarily 
associated with changes seen in the epithelial layer. Comparing the epithelial spectra of the 
normal and dysplastic raft cultures (figure 5.6b,c), definite differences can be observed.   The 
epithelial spectra from the dysplastic (SiHa) rafts show an relative increase in the 1325 cm-1 and 
1450 cm-1 peaks, two findings consistent with a study by Omberg, et al that looked at the 
changes in the Raman spectra of immortalized cells versus immortalized cells with the capacity 
to metastasize (via the addition of a T24Ha-ras oncogene) [29]. The corresponding stromal 
spectra do not show any significant differences; this would be expected since the stromal layer 
was kept constant.  Yet, there are many additional components present in the stromal layer in 
vivo (such as inflammatory cells, glandular structures, capillaries) which were not included in the 
construction of the raft cultures. To fully understand how the stromal layer contributes to the 
overall spectra and thus affects diagnosis, these structures should be added to the tissue culture 
system one by one to determine which spectral features are influenced by these stromal layer 
components.  
 In comparison with the Raman spectra of normal keratinocyte rafts, spectra from both the 
SiHa and the A431 rafts (two different squamous carcinoma cell lines) show similar spectral 
differences, a relative increase in intensity of the peaks at 1325 cm-1 as well as 1450 cm-1. The 
primary difference between the Raman spectra of the two different dysplasia rafts appears to be 
an increase in a small peak at 1307 cm-1. This subtle difference seen between the spectra of the 
A431 and SiHa rafts indicates that different cell lines leading to the same overall pathology can 
have subtle biochemical differences which can be detected using Raman spectroscopy.  
Similarly, in human tissues in vivo, differences in the epithelial cells can lead to the same end 
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pathology, even though biochemically these lesions may be completely different.  Raman 
spectroscopy may be used to detect these biochemical variations. On the other hand, these 
differences may also be a source of variability in clinical Raman spectra as lesions are typically 
categorized by their pathological diagnosis rather than the biochemical reality, possibly leading 
to problems of misclassification. 
 The spectral changes associated with the increase in epithelial thickness (figure 5.7) 
indicate that the spectral changes seen in spectra of dysplastic raft cultures as compared with 
normal raft cultures are in part due to the difference in epithelial thickness. On day 4, the spectra 
of the SiHa raft culture resembles the spectra measured from NHK rafts. The spectral increases 
seen in figure 5.7d at 1321, 1450 and 1657 cm-1 from day 4-14 are similar to differences seen in 
figure 5.5 between normal and dysplastic spectra.  Since the epithelial layer in the raft cultures 
increases in thickness and density from day 4-14, the observed decrease in intensity of the peak 
at 1048 cm-1 is a similar phenomenon to the one described above in the NHK/SiHa comparison. 
Because this peak is relatively large, the change in contribution affects the intensity of the 
remaining peaks through the mean intensity normalization procedure.  This makes the 
interpretation of the remaining changes in peak intensity problematic. Simple subtraction of a 
background measurement to eliminate the silica peaks is not possible since the tissue optical 
properties of each raft culture affects the amount of reflection of laser light back into the fiber-
optic probe thus affecting the size of the silica Raman peaks. Vector subtraction of the silica 
Raman peaks is one possible solution employed in another study of tissue Raman spectroscopy 
using the same fiber-optic probe [11]. Another solution would be to truncate the spectra below 
1200 cm-1 which would eliminate the spectral regions of silica Raman peaks; this method would 
also eliminate the peaks at 1006, 1055, and 1086 cm-1 which are likely peaks from the tissue.   
Regardless of artifacts due to spectral normalization, these results indicate that the changes seen 
in spectra of dysplastic raft cultures are due in part to the increase in epithelial thickness as 
compared with normal raft cultures.  Thus, it is conceivable that Raman spectroscopy may not 
detect dysplastic changes in cases in which the epithelial layer has been denuded. Yet, results 
from the Omberg, et. al. study indicate that metastatic cells have Raman spectral changes as 
compared with cells without the ability to metastasize independent of thickness or quantity [29]. 
Thus, the spectral changes of dysplasia are not solely due to the thickness effect. If spectra of 
epithelium and stroma could be measured independently, the effects of thickness could be 
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delineated from the true differences of dysplasia versus normal epithelium. This should be taken 
into consideration when designing Raman spectroscopy systems for the future clinical detection 
of cervical dysplasia. 
 In conclusion, organotypic cultures hold promise as a model system that can be 
manipulated and controlled to better understand the relationship between tissue components and 
tissue optical spectra.  This study indicates the potential of raft cultures, a type of organotypic 
culture, as a model system to understand the morphologic and biochemical basis of optical 
spectroscopy using Raman spectroscopy as one type of tissue spectroscopy. The results 
presented here indicate the effect of one perturbation of this model system (alteration of 
epithelial cell content) to show how such a model system could be used to better understand how 
changes in tissue biology affect tissue spectra. While further studies are planned for a thorough 
understanding of cervical tissue Raman spectroscopy, this technology could easily be adopted to 
other organ systems as well as other types of spectroscopic detection. 
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6.1  Summary 
 The research presented in this dissertation represents the next step in evaluating the 
potential of using Raman spectroscopy for differential diagnosis in the cervix. Several key 
advances were made to the field of tissue Raman spectroscopy. First, the study in chapter 3 
represents the largest in vivo study using Raman spectroscopy for the detection of dysplastic and 
cancerous changes to date. Secondly, the analysis of variance in chapter 4 quantified the spectral 
variance present from different sources using a method not previously used in Raman spectral 
analysis of tissue. Although the sources of variability examined in chapter 4 were specific to the 
cervix, the results give insight to the nature of variance of Raman spectra within a given 
pathology category. Lastly, the development of the organotypic raft culture model as an in vitro 
system for understanding the biochemical and cellular basis of spectral changes seen in vivo 
introduces a method for addressing basic science questions regarding the effect of tissue biology 
on Raman spectra.  
 In the first clinical study described in chapter 3, the Raman spectra were characterized for 
the following cervical tissue pathology categories: normal ectocervix (squamous epithelium), 
normal endocervix (columnar epithelium), squamous metaplasia, low grade dysplasia, and high 
grade dysplasia.  Peak intensities differences that were statistically significant between normal 
ectocervix and high grade dysplasia spectra were used to build an unbiased logistic regression 
algorithm using independent training and test data sets. The algorithm maximally separated the 
two categories with a sensitivity similar to and specificity superior to colposcopy. The remaining 
pathology categories were included in the test set, and although only 2/3 of the squamous 
metaplasia classified with the normal ectocervix (or “benign”), the majority of the normal 
endocervix were correctly classified as normal.  The low grade dysplasia tended to classify in the 
middle as would be expected as low grade dysplasia is an intermediate step in the progression 
from normal ectocervix to high grade dysplasia. A second algorithm was developed to improve 
the specificity of the first algorithm. Using logistic regression, the second algorithm was trained 
to discriminate between spectra from squamous metaplasia and high grade dysplasia; some of the 
same spectra used in the training set for the second algorithm were also included in the test set, 
and thus this algorithm is biased.  Even though the cross validation of this second algorithm is 
not an accurate estimate of the future ability of this algorithm to classify spectra, it does show 
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how such a multiple algorithm model system could be used to maximally classify spectra into 
multiple pathology categories.   
 Thus, my research has shown that Raman spectroscopy can distinguish high grade 
dysplasia from benign areas of the cervix. Though future studies are needed to further evaluate 
the accuracy of the classification, the studies presented establish the groundwork to develop 
Raman spectroscopy as a non-invasive, real-time diagnostic tool for lesions on the cervix.  
Although there have been numerous reports of Raman spectroscopy sucessfully performing 
diagnosis in vitro, very few studies to date have investigated its potential in vivo. Thus, the 
current work represents a significant  advance in the understanding of the power and limitations 
of Raman spectroscopy for diagnosis in the clinic and operating room settings.  Many of the in 
vitro studies in the literature have only used biopsy samples with a single pathology throughout 
the specimens. This method allows for the collection and delineation of the pure Raman spectral 
signature for a given pathology, it does not provide an accurate assessment of the capability of 
the technology to perform diagnosis in a clinical setting in which tissue biology has many spatial 
variations in pathology. By conducting research in a clinic setting, the variabilities and 
inaccuracies due to variations in tissue biology, different physician practices, and time 
constraints become part of the accuracy estimates, thereby yielding a more realistic assessment 
of the true ability of the technology to be developed into a diagnostic tool.  
 The second clinical study (chapter 4) examined the sources of variation within the Raman 
spectra of a single pathology category.  The main source of variation was found to originate in 
patient to patient variability.  Menopausal status was shown to be one component of this 
interpatient variability. The effect of application of acetic acid was also studied. The results show 
that although there are no time dependent spectral changes due to the application of acetic acid, 
there are 2 small non-significant differences in peak intensities.  Another source of interpatient 
variation seems to be differences between normal spectra measured from normal patients and 
normal spectra measured from patients with dysplasia. 
 Although several other studies have looked at the Raman spectral variance using different 
methods, the analysis of variance presented here represents the first study which quantifies the 
contributions of variance from different sources. By understanding the sources of variation, 
future clinical studies can be optimized and the future performance of the technology can be 
better evaluated.  For example, menopausal status was shown to be a significant source of 
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interpatient variation, particularly in the spectral region from 1240-1330 cm-1, a region which in 
chapter 3 was shown to be important for discrimination. Based on this finding, future studies 
need to be designed such that the data will be stratified according to menopausal status, and 
separate discrimination algorithms can be developed for each group which will likely improve 
the accuracy of classification.   
 The observation that normal spectra measured from normal patients have significantly 
different spectral features from normal spectra measured from patients with dysplasia is an 
unparalleled finding which will have implications for future research throughout the field of 
tissue Raman spectroscopy. Although it remains unclear what if anything these spectral 
differences represent, it could indicate that Raman spectroscopy can detect subcellular 
transformations prior to any change visible upon histological examination.  It also indicates that 
the spectra may need to be stratified to reflect overall patient diagnosis. If such a finding holds 
true in other organ sites in addition to the cervix, it will require a global transformation in the 
way clinical research are conducted to evaluate tissue spectroscopy.   Studies will have to include 
a subset of normal patients, or patients without evidence of disease, which is considerably more 
difficult for investigations at organ sites other than the cervix.  
 The raft culture studies (chapter 5) give insight into the biochemical and cellular basis for 
the differences seen between normal and dysplastic Raman spectra.  Histological and spectral 
comparisons of raft cultures with in vivo cervical tissue illustrates that raft cultures are a good in 
vitro model system for in vivo conditions.  Difference spectra measuring the divergence of 
dysplasia from normal spectra showed that the raft culture spectra show similar deviations as are 
seen in vivo with the exception of the 1450 cm-1 peak.  Spectra measured individually of epithelia 
and stroma revealed that the 1325 cm-1 peak originates primarily in the epithelial layer whereas 
the 1272 cm-1 peak has virtually no contribution from the epithelial layer and is primarily 
associated with the type I collagen in the stromal layer.  All other peaks have equal contributions 
from both the epithelial and stromal layers.  
 While raft cultures have been used as a effective model system in fields such as cell 
biology and virology, the work described in chapter 5 represents the first use of such a novel 
model system for understanding the biological basis of tissue spectra. If spectral differences can 
be linked to known biological changes present in the neoplastic transformation, then those 
spectral differences can be preferentially used in the development of diagnostic algorithms.  
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Spectral differences which are linked with known biological phenomena are more likely to be 
present in future data sets, thus increasing the likelihood of robust algorithm development. The 
experiments detailed in chapter 5 illustrate that spectral differences found in the 1300-1330 
region between normal and dysplastic rafts result from the increase in total nucleic acid as a part 
of changes in the epithelial cell content. Since these biological changes are seen consistently in 
the transformation from normal to dysplastic epithelium, this region of the spectra will continue 
to be a critical region for distinguishing the two pathologies. Thus, the inclusion of this region in 
any discrimination algorithm will likely yield a more robust algorithm as these spectral 
differences are biologically based rather than based on the statistical differences of the current 
study population.  
 This raft culture model system could also be applied in other types of optical 
spectroscopy and other organ systems. This system represents a completely unique way of 
addressing the question of how the biology of the tissue affects the spectra. Most other studies 
aimed at understanding the biology underlying tissue spectra have used frozen tissue. Yet, frozen 
tissue studies are limited by the numbers of specimens collected and the fact that the tissue is no 
longer viable.  Raft cultures overcome these limitations. First, because the cultures yield 
reproducible spectra, a conclusion can be drawn within the context of a few repeatable 
experiments. Since the components of the raft cultures are known ahead of time and can be 
altered, the contribution and effect of a certain tissue component can be determined, as opposed 
to frozen tissue spectroscopy in which tissue components are fixed and quantities are unknown. 
So instead of using the spectroscopy to quantitate the amount of a certain tissue component, the 
raft culture model system uses changes in the amounts of tissue components to determine the 
effect of that tissue component on tissue spectroscopy.  This represents a shift in perspective and 
a method of collecting information not possible with the frozen tissue spectroscopy.    
 Overall, the following conclusions can be made from the data: 
(1) There are statistically significant differences between high grade dysplasia and “benign” 
cervix (normal ectocervix, squamous metaplasia) that can be 
used to build discrimination models. Visual distinctions are present in the mean spectra of low 
grade dysplasia and categories of benign cervix indicating potential regions for use in future 
discrimination algorithms.  
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(2) An single algorithm logistic regression model can distinguish high grade dysplasia from 
normal ectocervix with slightly better accuracy than colposcopy using unbiased estimates. A 
second algorithm added to the model improves the accuracy of the discrimination of squamous 
metaplasia using biased estimates of accuracy. 
(3) With the collection of more spectra in all pathology categories, independent training and test 
sets can be used to develop algorithms which could distinguish each of the pathology categories 
individually. 
(4) The majority of the variance seen in spectra of normal ectocervix emanates from patient to 
patient variation.  Intrapatient (or location) variation contributes very little to the total variance; 
thus, repeat measurements of normal sites within a given patient are not necessary.  Additional 
research into the sources of interpatient variation is needed. 
(5) Menopausal status is one contributor of interpatient variation.  Because there is a significant 
difference in the peak at 1324 cm-1, a peak associated with nucleic acid found primarily in the 
epithelial layer. Since this peak is significantly different between spectra from high grade 
dysplasia, normal ectocervix, and squamous metaplasia, it is likely to continue to be necessary 
for discrimination, and therefore, it may be necessary to stratify the data according to 
menopausal status in future studies. 
(6) Another contributor of interpatient variation can be found in the differences seen between 
normal spectra measured from patients with normal cervices and patients with cervical dysplasia.  
Although sources of these discrepancies are unknown, this finding indicates that Raman 
spectroscopy may be detecting subcellular changes not apparent upon routine histologic 
examination.  
(7) Results from the acetic acid analysis indicate that the application of acetic acid enhances two 
of the spectral changes between normal and dysplasia spectra, and thus it would be advisable to 
always apply acetic acid prior to spectral measurement, though regulation of the time after 
application is not critical.  
(8) The results from the raft culture data provides insight into the origins of some of the spectral 
peaks: 
(a) The 1324 cm-1 peak originates primarily in the epithelial layer, likely from the nucleic 
acid present in epithelial cells. 
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(b) The 1272 cm-1 peak originates primarily in the stromal layer, likely from the type I 
collagen. 
(c) The remainder of the major peaks have origins in both the epithelial and stromal 
layers. 
(d) Changing the epithelial cell content from normal keratinocytes to squamous cell 
carcinoma cells induces the same spectral changes seen when comparing in vivo normal 
and dysplastic spectra, with the exception of the 1450 cm-1 peak. This indicates that the 
change in the 1450 cm-1 peak in dysplasia is likely a result of changes occurring in the 
stromal layer, since this was not changed in the raft culture model. 
(e) The spectral changes seen in the dysplastic rafts as compared with the normal rafts are 
in part due to the increased epithelial thickness present in dysplasia. 
 
6.2  Limitation of Current Results and Future Directions 
 This work represents the next step in evaluating the potential of Raman spectroscopy as a 
tool in the screening and diagnosis of cervical dysplasia. Yet, a significant amount of evaluation 
of this technology and basic science research to understand the biological basis for the spectral 
changes observed must occur before this technology can begin to be implemented in a clinical 
situation.   
  First, larger clinical studies must be conducted to gain the amount of data necessary to to 
validate the ability of Raman spectroscopy to distinguish multiple different pathologies in the 
cervix. Larger data sets will allow for an adequate size training and test set for robust algorithm 
development and analysis.  Specifically, an increase in the numbers of low grade dysplasia and 
normal endocervix spectra will allow for the development of discrimination algorithms for these 
categories. Then a multiple algorithm model can be developed to accurately distinguish all 
pathology categories instead of relying on one or two algorithms as was used in this research.   
Based on the results from the variability analysis in chapter 5, larger numbers of spectra also are 
needed to stratify according to menopausal status; acquiring the numbers of patients necessary to 
accomplish this will be difficult as most patients presenting with cervical dysplasia are pre-
menopausal, yet doing so should improve the accuracy of classification. Lastly, studies should be 
conducted at multiple centers to gain a more diverse population of patients.   
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 The evidence that Raman spectroscopy can distinguish between high grade dysplasia and 
normal ectocervix is strong, but far from decisive.  Issues of whether or not high grade dysplasia 
can be detected when the epithelium is thin or has been denuded need to be resolved. One 
possible solution would be to design a fiber-optic probe to collect light separately from the 
epithelial and stromal layers. Thus the effect of the thickness of the epithelium would have less 
of an effect on the overall spectrum, and the spectral difference between the dysplastic and 
normal epithelial cells could be detected regardless of the thickness of the epithelium. 
Distinguishing squamous metaplasia from dysplasia is not only a challenge for colposcopists, but 
it also seems to be a challenge with Raman spectroscopy.  There are areas of statistical 
differences between squamous metaplasia and high grade dysplasia spectra, but whether these 
differences will be sufficient to enable accurate discrimination remains to be seen. Regardless, 
the collection of a larger data set should increase the accuracy of discrimination since the larger 
the training set, the more accurate the results will be. Preliminary examination show visual 
distinctions between spectra of low grade dysplasia and benign cervix, a larger sample size will 
determine the stastical validity of these variations. 
 Although the Raman spectroscopy system used in the studies presented here represents a 
great improvement over the system used in the original pilot study using Raman spectroscopy to 
detect cervical dysplasia [1], further improvements to the current system are needed to improve 
the quality of the clinical studies.  The main limitations of the current system include: 
interference of ambient room light with the quality of the spectra and the lack of an accurate 
system to mark the tissue at the site of spectral measurement. Improvements in the design of the 
fiber-optic probe could aid in the solution of these problems. The probe could be designed to 
physically block any ambient light present at the tissue by including material to surround the 
fiber-optics at the probe tip. An increase in the collection efficiency of the probe also would 
decrease the amount of ambient light collected by the probe by reducing the length of the 
integration time required for measurement.  A decreased integration time would also improve the 
clinical utility of the system. Incorporating a marking system which could be intrinsic to the 
probe itself should also be investigated as a means to improve the current marking system.  
 Additional research is also needed to develop techniques to aid in the development of  
robust diagnostic algorithms. Currently, there is no consensus in the field of biomedical Raman 
spectroscopy on the best methods to use in algorithm development, although there is agreement 
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on the need for unbiased data analysis and independent validation. A variety of statistical 
methods typically are used by different research groups to design an algorithm which will 
maximally separate the data at hand. Logistic Regression was chosen based on the nature of the 
desired classification and the amount of data available. Yet, if a study were to compare different 
methods used by different research groups and empirically determine which methods were 
superior, it could help standardize and improve the process of algorithm development throughout 
the field.  Another method for improving algorithm development lies in understanding the 
biochemical and cellular basis for the spectral differences between pathology groups.  The raft 
culture experiments presented here give us one example of how understanding the biological 
basis for the spectral features can aid in algorithm development.  A continuation of the raft 
culture experiments should improve not only the understanding of the effect of biological 
variables on the tissue spectra but also the development of robust algorithms and accuracy of 
classification. 
 The analysis of variance uncovered the basic sources of variability present within normal 
spectra.  Further research should expound upon these findings to examine other potential sources 
of interpatient variability.  There were several potential demographic sources of variation which 
were unable to be evaluated in this study for various reasons including menstrual cycle status, 
race, and pregnancy status; these should be evaluated in future studies.  Also, based on the 
results in this study, future studies should stratify the data according to menopausal status and 
develop separate classification algorithms which should improve the accuracy of classification.  
The source of the discrepancies seen between normal spectra measured in patients with normal 
cervices and patients with dysplasia should also be investigated further.  It may be necessary to 
create separate categories for these two groups until a more basic understanding of what is 
causing these spectral differences is uncovered. 
 The raft culture model presents a method in which many of these basic science questions 
can be addressed.  Thus far, the only perturbations of the model system have been in the 
epithelial layer, yet there are indications from studies in fluorescence spectroscopy that there are 
changes occurring in the stromal layer in dysplasia before invasion occurs [2,3].  Additionally, 
one major discrepancy at 1450 cm-1 was seen in the dysplastic-normal comparison between the 
in vivo and the raft culture data. Since no changes were made to the stromal layer, this 
discrepancy is likely due to changes in the stromal layer. The first step in investigating these 
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changes would be through the addition of tumor associated fibroblasts to the stromal layer. The 
addition of these fibroblasts will allow a more accurate representation of the stromal 
environment present in dysplasia, and could prove to be the factor behind the discrepancy at 
1450 cm-1.  The overall effect of fibroblasts should also be examined since the fibroblast 
concentration was held constant for these studies. If a rigorous comparison of the concentration 
of fibroblasts in vivo and raft cultures could be performed, it may aid to optimize the model 
system. There are also other structural and cellular components present in the in vivo stromal 
layer which were not included in the initial raft culture experiments, specifically basement 
membrane, proteoglycans, and laminin [4].  These components should be added one by one to 
determine their affect on the overall Raman spectra. Inflammatory cells were not included in the 
composition of the stromal layers.  Although inflammatory cells are always present at a basal 
level in the cervical stroma, the amount and type of inflammatory cells will vary depending on 
the state of the tissue and external environment (i.e. presence or absence of pathogens). The 
effect of acute and chronic inflammation on the tissue spectra can be studied by adding differing 
concentrations of poly-nuclear leukocytes or mono-nuclear leukocytes, respectively. Mature 
macrophages are often found in tissue as well and could be added to simulate their effect.  
Although several alterations were made to the epithelial layer in the studies presented in chapter 
5, the experiments only looked at the differences between normal and high grade dysplasia, with 
no investigation of low grade dysplasia. By adding epithelial cells infected with low-risk strains 
of HPV, the spectral changes seen in low grade dysplasia could be examined.  These 
perturbations of the model will allow for a further evaluation of the biochemical and cellular 
basis of the Raman spectra.  
 This dissertation research shows that Raman spectroscopy can distinguish dysplasia from 
normal cervix in vivo and non-invasively.  Yet, further research is needed to validate this finding, 
develop more robust discrimination algorithms, and advance the techonology and design a 
system which can be used with minimal training.  The reproducibility of classification currently 
is not good enough to warrant replacing the standard of care (colposcopy directed biopsy). Yet, 
collection of larger data sets should enable the development of more robust algorithms since, 
theoretically, the larger the training set used to develop the algorithm, the better future 
classification will be. Also, if more information regarding the biologic basis of spectral features 
can be gained from raft culture experiments and frozen tissue spectroscopy, that information 
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should also improve algorithm development and thus classification. Diagnostic accuracy may 
also improve if Raman spectroscopy is combined with another spectroscopic method. 
Fluorescence spectroscopy is one possibility. Whereas Raman spectroscopy provides a spectral 
fingerprint of the chemical bonds present in the tissue and thus is a very specific technique, 
fluorescence spectroscopy provides measure of the metabolic state of the tissue and has good 
overall sensitivity. A system could be designed to take advantage of both of these modalities in 
which fluorescence spectroscopy is used first to scan the cervix and detect suspecious areas, 
followed by a Raman “optical biopsy” to provide a more specific diagnosis of those suspecious 
areas. Other potential types of spectroscopy include diffuse reflectance and light scattering 
spectroscopy which have both been examined in combination with fluorescence for diagnosis in 
the cervix  [5].  Of the two, light scattering spectroscopy improved the performance of 
fluorescence the most and likely holds the most promise for improving the accuracy of Raman 
spectroscopy.  Light scattering spectroscopy measures the reflected light only from the surface 
epithelial cells. This may aid in the detection of high grade dysplasia in cases when the 
epithelium is thin or has been denuded since the thickness of the epithelium does not affect the 
spectrum in light scattering spectroscopy.   
 Taking all of these points into consideration, Raman spectroscopy does have a realistic 
potential for becoming a more accurate and cost-effective method of screening for cervical 
cancer either alone or in combination with other spectroscopic modalities. Thus, research into 
developing the technology as a diagnostic tool should continue, and should focus particularly on 
collecting larger data sets for algorithm training and understanding the biological basis for tissue 
spectra. 
 
6.3  Protection of Research Subjects 
 For this technology to be truly evaluated in its ability for noninvasive diagnosis, clinical 
studies must establish the validity of the technique in the clinical and operating room setting. 
Human subjects have participated as part of both the in vivo clinical dysplasia and normal studies 
of the cervix (as described in chapters 3-4). Additionally, the in vitro raft culture studies aimed at 
understanding the underlying mechanisms as described in chapter 5 necessitate the use of human 
cell lines in the preparation of these tissue cultures and a small number (5) of human cervical 
tissue to validate the model system. 
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 For the in vivo clinical studies, the Vanderbilt Institutional Review Board reviewed and 
approved the two separate protocols entitled “Detection of Cervical Precancers Using Near 
Infrared Raman Spectroscopy: A Pilot In Vivo Study” (IRB# 010245) and “Study of Normal 
Cervix Using Raman Spectroscopy” (IRB # 02-0345). Informed consent was obtained prior to 
each study, and patients had the right to refuse to participate or withdraw from the study at any 
time without compromising their care.  Adult patients are included in the study without regard to 
race, ethnicity, or age. The clinical study added no pain to the procedure, and steps were taken to 
minimize any additional inconvenience or discomfort the patient might experience due to the 
increased time required for the study.   
 The use of organotypic cultures is designed to minimize the need to use human and 
animal tissues. Yet the use of such cultures was supplemented and validated using tissue from 
actual patients. The Vanderbilt IRB approved a protocol to obtain cervix samples from 
hysterectomy specimens. Only tissue not needed for patient care was used, and no patient 
information was used for the in vitro studies.  Human cell lines were obtained from the American 
Tissue Type Collection and the Cambrex Corporation. 
 
6.4  Societal Benefits 
 The benefits to society have been documented in the background and introduction. In 
brief, Raman spectroscopy has the potential to be a more accurate and less expensive method of 
screening and diagnosing cervical dysplasia.  The ability of Raman spectroscopy to enable a see 
and treat protocol would decrease the number of return clinic visits and patient anxiety as the 
long waits for histopathology diagnoses would be eliminated. Thus, the technology has the 
potential to increase access to underserved populations where follow-up to screening may not be 
available. The technology poses no known risks to the patient, and therefore could be a safe 
alternative to current screening methods. 
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